| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | CACNA1F TRPV1 ABCA12 ABCA13 ATP13A1 TRPC1 PIEZO1 OTOP2 SLC19A3 ABCC9 GRID2 ANO5 SLC12A8 ATP10B ATP9B APOB GRIK4 GRIN2A GRIN2B ATP13A2 SLC9C2 ABCA7 SLC26A1 SLC16A12 RHCE RYR2 OPRM1 SLC30A6 MFSD14A SLC22A9 GSDME IGF1R SLC12A3 SLC16A5 ABCA5 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 PKD2 SCN10A TMEM184C SLC36A3 CACNA1I CACNA1H CACNA1G ATP13A3 ATP2B1 ANO3 SLC4A11 | 5.53e-21 | 1289 | 165 | 50 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1F TRPV1 ABCA12 ABCA13 ATP13A1 TRPC1 PIEZO1 OTOP2 SLC19A3 ABCC9 GRID2 ANO5 SLC12A8 GRIK4 GRIN2A GRIN2B ATP13A2 SLC9C2 ABCA7 SLC26A1 SLC16A12 RHCE RYR2 OPRM1 SLC30A6 MFSD14A SLC22A9 GSDME SLC12A3 SLC16A5 ABCA5 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP13A3 ATP2B1 ANO3 SLC4A11 | 1.63e-18 | 1180 | 165 | 45 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1F TRPV1 ATP13A1 TRPC1 PIEZO1 OTOP2 ABCC9 GRID2 ANO5 SLC12A8 GRIK4 GRIN2A GRIN2B ATP13A2 SLC9C2 SLC26A1 RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP13A3 ATP2B1 ANO3 SLC4A11 | 1.17e-14 | 793 | 165 | 33 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1F TRPV1 ATP13A1 TRPC1 PIEZO1 OTOP2 ABCC9 SLC12A8 GRIK4 GRIN2A GRIN2B ATP13A2 SLC9C2 RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP13A3 ATP2B1 SLC4A11 | 1.77e-13 | 664 | 165 | 29 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1F TRPV1 ATP13A1 TRPC1 OTOP2 ABCC9 ANO5 SLC12A8 GRIK4 GRIN2A GRIN2B SLC9C2 SLC26A1 RHCE RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP2B1 ANO3 SLC4A11 | 8.09e-13 | 758 | 165 | 30 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1F TRPV1 ATP13A1 TRPC1 OTOP2 ABCC9 SLC12A8 GRIK4 GRIN2A GRIN2B SLC9C2 RHCE RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP2B1 SLC4A11 | 1.86e-12 | 627 | 165 | 27 | GO:0022890 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1F TRPV1 ATP13A1 TRPC1 ABCC9 SLC12A8 GRIK4 GRIN2A GRIN2B SLC9C2 RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 SLC6A20 PKD2 SCN10A CACNA1I CACNA1H CACNA1G ATP2B1 SLC4A11 | 5.97e-12 | 465 | 165 | 23 | GO:0046873 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA12 ABCA13 ATP13A1 ABCC9 SLC12A8 ATP13A2 SLC9C2 ABCA7 SLC26A1 SLC16A12 SLC30A6 SLC22A9 SLC12A3 SLC16A5 ABCA5 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 SLC36A3 ATP13A3 ATP2B1 SLC4A11 | 1.00e-11 | 477 | 165 | 23 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR5W2 XCR1 NPBWR2 OR8J2 OR8J3 TRPV1 OR8D1 HTR2B OR2T27 OR5AS1 OR1S2 OR8K5 GPR55 GPR87 ABCC9 NMUR1 GRID2 OR6C65 GRIK4 GRIN2A GRIN2B ADGRV1 ABCA7 GPR139 OPRM1 IFNAR2 TGFBR3 IGF1R PTPRA P2RY1 ADGRG2 P2RY14 TACR3 TAS2R39 TAS2R30 ADGRL2 ADGRL3 | 7.27e-11 | 1353 | 165 | 37 | GO:0004888 |
| GeneOntologyMolecularFunction | channel activity | CACNA1F TRPV1 TRPC1 PIEZO1 OTOP2 ABCC9 GRID2 ANO5 GRIK4 GRIN2A GRIN2B RHCE RYR2 OPRM1 GSDME PKD2 SCN10A CACNA1I CACNA1H CACNA1G ANO3 SLC4A11 | 4.26e-10 | 525 | 165 | 22 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1F TRPV1 TRPC1 PIEZO1 OTOP2 ABCC9 GRID2 ANO5 GRIK4 GRIN2A GRIN2B RHCE RYR2 OPRM1 GSDME PKD2 SCN10A CACNA1I CACNA1H CACNA1G ANO3 SLC4A11 | 4.41e-10 | 526 | 165 | 22 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1F TRPV1 TRPC1 PIEZO1 OTOP2 ABCC9 GRID2 ANO5 GRIK4 GRIN2A GRIN2B RYR2 OPRM1 PKD2 SCN10A CACNA1I CACNA1H CACNA1G ANO3 SLC4A11 | 1.45e-09 | 459 | 165 | 20 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1F TRPV1 PIEZO1 ABCC9 GRID2 ANO5 GRIK4 GRIN2A GRIN2B RYR2 OPRM1 PKD2 SCN10A CACNA1I CACNA1H CACNA1G ANO3 | 2.66e-09 | 334 | 165 | 17 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1F TRPV1 TRPC1 PIEZO1 OTOP2 ABCC9 GRIK4 GRIN2A GRIN2B RYR2 OPRM1 PKD2 SCN10A CACNA1I CACNA1H CACNA1G SLC4A11 | 3.97e-09 | 343 | 165 | 17 | GO:0005261 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1F TRPV1 TRPC1 GRIN2A GRIN2B RYR2 OPRM1 PKD2 CACNA1I CACNA1H CACNA1G ATP2B1 | 4.71e-09 | 151 | 165 | 12 | GO:0015085 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.20e-09 | 49 | 165 | 8 | GO:0140359 | |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1F TRPV1 TRPC1 GRIN2A GRIN2B RYR2 OPRM1 PKD2 CACNA1I CACNA1H CACNA1G | 1.01e-08 | 129 | 165 | 11 | GO:0005262 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5W2 XCR1 NPBWR2 OR8J2 OR8J3 OR8D1 HTR2B OR2T27 OR5AS1 OR1S2 OR8K5 GPR55 GPR87 NMUR1 OR6C65 ADGRV1 GPR139 OPRM1 P2RY1 ADGRG2 P2RY14 TACR3 TAS2R39 TAS2R30 ADGRL2 ADGRL3 | 1.74e-08 | 884 | 165 | 26 | GO:0004930 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | ABCA12 ABCA13 ATP13A1 ABCC9 ATP13A2 ABCA7 ABCA5 ATP6V0A4 ATP13A3 ATP2B1 | 2.38e-08 | 109 | 165 | 10 | GO:0042626 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 9.45e-08 | 46 | 165 | 7 | GO:0005245 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | GRIK4 SLC9C2 SLC12A3 SLC20A2 SLC6A20 PKD2 SCN10A CACNA1I CACNA1H CACNA1G SLC4A11 | 1.85e-07 | 171 | 165 | 11 | GO:0015081 |
| GeneOntologyMolecularFunction | sodium channel activity | 2.27e-07 | 52 | 165 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1F TRPV1 ABCC9 GRIN2A GRIN2B OPRM1 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 3.47e-07 | 182 | 165 | 11 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1F TRPV1 ABCC9 GRIN2A GRIN2B OPRM1 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 3.88e-07 | 184 | 165 | 11 | GO:0022832 |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 5.54e-07 | 3 | 165 | 3 | GO:0008332 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCA12 ABCA13 ANO5 ATP10B ATP9B APOB ABCA7 SLC22A9 ABCA5 SLCO1A2 ANO3 | 7.27e-07 | 196 | 165 | 11 | GO:0005319 |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.03e-06 | 93 | 165 | 8 | GO:0097110 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A8 SLC9C2 SLC26A1 SLC16A12 SLC30A6 SLC22A9 SLC12A3 SLC16A5 SLC20A2 SLCO1A2 SLC6A20 SLC36A3 SLC4A11 | 1.14e-06 | 296 | 165 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC19A3 GRIK4 GRIN2A GRIN2B SLC26A1 SLC16A12 SLC22A9 SLC16A5 SLCO1A2 SLC6A20 SLC36A3 | 1.25e-06 | 207 | 165 | 11 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC19A3 GRIK4 GRIN2A GRIN2B SLC26A1 SLC16A12 SLC22A9 SLC16A5 SLCO1A2 SLC6A20 SLC36A3 | 1.31e-06 | 208 | 165 | 11 | GO:0005342 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP13A1 ABCC9 SLC12A8 ATP13A2 SLC9C2 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 SLC36A3 ATP13A3 ATP2B1 | 1.37e-06 | 301 | 165 | 13 | GO:0022853 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.07e-06 | 26 | 165 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | ABCA12 ABCA13 ATP13A1 ABCC9 ATP13A2 ABCA7 ABCA5 ATP6V0A4 ATP13A3 ATP2B1 | 2.33e-06 | 178 | 165 | 10 | GO:0015399 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 DNAH10 ABCA12 ABCA13 ATP13A1 MYO1H ACTB ABCC9 ATP10B ATP9B ATP13A2 ABCA7 DNAH14 ACSL3 ABCA5 ATP6V0A4 ATP13A3 ATP2B1 | 3.46e-06 | 614 | 165 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.85e-06 | 51 | 165 | 6 | GO:0140303 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.22e-06 | 14 | 165 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.81e-06 | 193 | 165 | 10 | GO:0015276 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | CACNA1F TRPV1 ABCC9 GRIN2A OPRM1 PKD2 CACNA1I CACNA1H CACNA1G | 4.93e-06 | 152 | 165 | 9 | GO:0022843 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 5.18e-06 | 31 | 165 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.77e-06 | 197 | 165 | 10 | GO:0022834 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC19A3 GRIK4 GRIN2A GRIN2B SLC26A1 SLC16A12 SLC22A9 SLC16A5 SLCO1A2 SLC6A20 SLC36A3 SLC4A11 | 6.10e-06 | 293 | 165 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.11e-05 | 36 | 165 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.11e-05 | 36 | 165 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.22e-05 | 62 | 165 | 6 | GO:0019829 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 DNAH10 ABCA12 ABCA13 ATP13A1 ACTB ABCC9 ATP10B ATP9B ATP13A2 ABCA7 ABCA5 ATP13A3 ATP2B1 | 1.86e-05 | 441 | 165 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | fatty acid elongase activity | 1.89e-05 | 7 | 165 | 3 | GO:0009922 | |
| GeneOntologyMolecularFunction | ABC-type polyamine transporter activity | 6.79e-05 | 2 | 165 | 2 | GO:0015417 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 6.80e-05 | 27 | 165 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 7.55e-05 | 53 | 165 | 5 | GO:0008188 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 7.88e-05 | 28 | 165 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 9.01e-05 | 171 | 165 | 8 | GO:0015103 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 1.49e-04 | 13 | 165 | 3 | GO:0045028 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.66e-04 | 140 | 165 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | symporter activity | 2.53e-04 | 150 | 165 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.46e-04 | 17 | 165 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 4.13e-04 | 18 | 165 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.13e-04 | 18 | 165 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 4.32e-04 | 43 | 165 | 4 | GO:0001965 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.43e-04 | 77 | 165 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 6.26e-04 | 83 | 165 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | odorant binding | 6.59e-04 | 127 | 165 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | single-stranded DNA 5'-3' DNA exonuclease activity | 6.68e-04 | 5 | 165 | 2 | GO:0045145 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 7.60e-04 | 22 | 165 | 3 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 7.60e-04 | 22 | 165 | 3 | GO:0001614 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 9.87e-04 | 24 | 165 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | protein-cysteine S-myristoyltransferase activity | 9.96e-04 | 6 | 165 | 2 | GO:0019705 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 9.96e-04 | 6 | 165 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.26e-03 | 57 | 165 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 1.39e-03 | 7 | 165 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 1.39e-03 | 7 | 165 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.39e-03 | 7 | 165 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | protein-cysteine S-stearoyltransferase activity | 1.39e-03 | 7 | 165 | 2 | GO:0140439 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.45e-03 | 100 | 165 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.53e-03 | 60 | 165 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.56e-03 | 28 | 165 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.80e-03 | 105 | 165 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.84e-03 | 8 | 165 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 1.84e-03 | 8 | 165 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.06e-03 | 65 | 165 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.06e-03 | 65 | 165 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 2.35e-03 | 9 | 165 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | 5'-3' DNA exonuclease activity | 2.35e-03 | 9 | 165 | 2 | GO:0035312 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 2.52e-03 | 33 | 165 | 3 | GO:0072349 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.52e-03 | 33 | 165 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.68e-03 | 167 | 165 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | single-stranded DNA exodeoxyribonuclease activity | 2.92e-03 | 10 | 165 | 2 | GO:0008297 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.11e-03 | 119 | 165 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 3.30e-03 | 74 | 165 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.46e-03 | 75 | 165 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 3.50e-03 | 37 | 165 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.50e-03 | 37 | 165 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 3.55e-03 | 11 | 165 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | structural constituent of myelin sheath | 3.55e-03 | 11 | 165 | 2 | GO:0019911 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 3.55e-03 | 11 | 165 | 2 | GO:0098973 | |
| GeneOntologyMolecularFunction | myristoyltransferase activity | 3.55e-03 | 11 | 165 | 2 | GO:0019107 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.83e-03 | 125 | 165 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 DNAH10 ABCA12 ABCA13 ATP13A1 ACTB ABCC9 ATP10B ATP9B ATP13A2 ABCA7 DCP1B ABCA5 ATP13A3 ATP2B1 | 4.15e-03 | 839 | 165 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 DNAH10 ABCA12 ABCA13 ATP13A1 ACTB ABCC9 ATP10B ATP9B ATP13A2 ABCA7 DCP1B ABCA5 ATP13A3 ATP2B1 | 4.19e-03 | 840 | 165 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 DNAH10 ABCA12 ABCA13 ATP13A1 ACTB ABCC9 ATP10B ATP9B ATP13A2 ABCA7 DCP1B ABCA5 ATP13A3 ATP2B1 | 4.19e-03 | 840 | 165 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 4.79e-03 | 188 | 165 | 6 | GO:0015078 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1F XCR1 TRPV1 HTR2B ATP13A1 TRPC1 PIEZO1 OTOP2 ABCC9 NMUR1 GRID2 ANO5 SLC12A8 GRIK4 GRIN2A GRIN2B ATP13A2 SLC9C2 SLC26A1 PXK RYR2 OPRM1 SLC30A6 SLC22A9 SLC12A3 P2RY1 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP13A3 ATP2B1 PLP1 ANO3 SLC4A11 | 8.73e-14 | 1374 | 164 | 41 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1F XCR1 TRPV1 HTR2B ATP13A1 TRPC1 PIEZO1 OTOP2 ABCC9 GRID2 ANO5 SLC12A8 GRIK4 GRIN2A GRIN2B ATP13A2 SLC9C2 SLC26A1 RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP13A3 ATP2B1 PLP1 ANO3 SLC4A11 | 3.97e-13 | 1115 | 164 | 36 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1F XCR1 TRPV1 HTR2B ATP13A1 TRPC1 PIEZO1 OTOP2 ABCC9 SLC12A8 GRIN2A GRIN2B ATP13A2 SLC9C2 RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP13A3 ATP2B1 PLP1 SLC4A11 | 1.39e-11 | 942 | 164 | 31 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1F XCR1 TRPV1 HTR2B ATP13A1 TRPC1 OTOP2 ABCC9 ANO5 SLC12A8 GRIN2A GRIN2B SLC9C2 SLC26A1 RHCE RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP2B1 PLP1 ANO3 SLC4A11 | 1.98e-11 | 1017 | 164 | 32 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1F XCR1 TRPV1 HTR2B ATP13A1 TRPC1 OTOP2 ABCC9 SLC12A8 GRIN2A GRIN2B SLC9C2 RHCE RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP2B1 PLP1 SLC4A11 | 2.02e-10 | 922 | 164 | 29 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1F XCR1 TRPV1 HTR2B ATP13A1 TRPC1 PIEZO1 OTOP2 ABCC9 SLC12A8 GRIN2A GRIN2B ATP13A2 SLC9C2 RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP13A3 ATP2B1 PLP1 SLC4A11 | 2.19e-09 | 1157 | 164 | 31 | GO:0006812 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5W2 CACNA1F OR8J2 OR8J3 TRPV1 OR8D1 OR2T27 OR5AS1 PIEZO1 OR1S2 CDS2 OR8K5 OR6C65 GRIN2A GRIN2B ADGRV1 LY96 RYR2 PKD2 SCN10A TAS2R39 TAS2R30 ANO3 | 1.48e-08 | 722 | 164 | 23 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5W2 XCR1 NPBWR2 OR8J2 OR8J3 OR8D1 HTR2B OR2T27 TRPC1 OR5AS1 OR1S2 OR8K5 ZDHHC7 GPR55 GPR87 NMUR1 OR6C65 ADGRV1 ZDHHC3 ADCY6 GPR139 OPRM1 P2RY1 ADGRG2 SYP P2RY14 TACR3 TAS2R39 TAS2R30 ADGRL2 ADGRL3 | 1.61e-07 | 1395 | 164 | 31 | GO:0007186 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | CACNA1F XCR1 TRPV1 HTR2B TRPC1 GRIN2A GRIN2B RYR2 PKD2 CACNA1I CACNA1H CACNA1G | 1.75e-07 | 217 | 164 | 12 | GO:0097553 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1F XCR1 TRPV1 HTR2B ATP13A1 TRPC1 ABCC9 SLC12A8 GRIN2A GRIN2B SLC9C2 RYR2 OPRM1 SLC30A6 SLC12A3 SLC20A2 SLC6A20 PKD2 SCN10A CACNA1I CACNA1H CACNA1G ATP2B1 PLP1 SLC4A11 | 3.58e-07 | 1000 | 164 | 25 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1F XCR1 TRPV1 HTR2B TRPC1 GRIN2A GRIN2B RYR2 OPRM1 PKD2 CACNA1I CACNA1H CACNA1G ATP2B1 PLP1 | 5.89e-07 | 392 | 164 | 15 | GO:0070588 |
| GeneOntologyBiologicalProcess | detection of external stimulus | CACNA1F TRPV1 PIEZO1 CDS2 GRIN2A GRIN2B ADGRV1 PKD2 SCN10A ANO3 | 1.28e-06 | 173 | 164 | 10 | GO:0009581 |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | CACNA1F TRPV1 PIEZO1 CDS2 GRIN2A GRIN2B ADGRV1 PKD2 SCN10A ANO3 | 1.42e-06 | 175 | 164 | 10 | GO:0009582 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | CACNA1F TRPV1 ABCC9 SLC12A8 SLC9C2 SLC12A3 CACNA1I CACNA1H CACNA1G | 2.06e-06 | 142 | 164 | 9 | GO:0099587 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | CACNA1F TRPV1 ABCC9 SLC12A8 SLC9C2 SLC12A3 CACNA1I CACNA1H CACNA1G | 2.06e-06 | 142 | 164 | 9 | GO:0098659 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 2.23e-06 | 75 | 164 | 7 | GO:0050982 | |
| GeneOntologyBiologicalProcess | lipid localization | ABCA12 ABCA13 VPS13C CDS2 ATP10B ATP9B APOB ABCA7 ACSL3 SLC22A9 ABCA5 OSBPL3 SLCO1A2 BSCL2 IL1A ANO3 SERPINA5 | 2.80e-06 | 565 | 164 | 17 | GO:0010876 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1F XCR1 HTR2B ATP13A1 TRPC1 SLC12A8 GRIN2B ATP13A2 SLC9C2 RHCE RYR2 SLC12A3 P2RY1 ATP6V0A4 PKD2 ATP13A3 IL1A ATP2B1 SLC4A11 | 3.54e-06 | 705 | 164 | 19 | GO:0055080 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5W2 CACNA1F OR8J2 OR8J3 TRPV1 OR8D1 OR2T27 OR5AS1 OR1S2 OR8K5 OR6C65 GRIN2A GRIN2B ADGRV1 SCN10A TAS2R39 TAS2R30 | 4.16e-06 | 582 | 164 | 17 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception | OR5W2 CACNA1F OR8J2 OR8J3 TRPV1 OR8D1 PDE6A OR2T27 OR5AS1 OR1S2 OR8K5 OR6C65 GRIN2A GRIN2B ADGRV1 PKHD1L1 OPRM1 GSDME ATP6V0A4 SCN10A TAS2R39 MARVELD2 TAS2R30 NIPBL | 4.31e-06 | 1072 | 164 | 24 | GO:0007600 |
| GeneOntologyBiologicalProcess | import into cell | CACNA1F TRPV1 HTR2B ABCA13 MYO1H ACTB NCKIPSD ACTG1 ABCC9 SLC12A8 ATP9B SLC9C2 ABCA7 ACSL3 SLC12A3 WASHC5 SLC6A20 IQSEC1 SYP CACNA1I CACNA1H CACNA1G ULK1 LY75 | 4.45e-06 | 1074 | 164 | 24 | GO:0098657 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1F XCR1 HTR2B ATP13A1 TRPC1 SLC12A8 GRIN2B ATP13A2 SLC9C2 RHCE RYR2 SLC12A3 P2RY1 ATP6V0A4 PKD2 ATP13A3 IL1A ATP2B1 SLC4A11 | 4.51e-06 | 717 | 164 | 19 | GO:0050801 |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1F XCR1 HTR2B ABCA12 ATP13A1 TRPC1 SLC12A8 APOB GRIN2B ATP13A2 SLC9C2 ADCY6 RHCE RYR2 IGF1R SLC12A3 P2RY1 ABCA5 WASHC5 SLCO1A2 ATP6V0A4 PKD2 ATP13A3 IL1A ATP2B1 SLC4A11 | 6.11e-06 | 1249 | 164 | 26 | GO:0048878 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC9C2 SLC12A3 SLC20A2 SLC6A20 PKD2 SCN10A CACNA1I CACNA1H CACNA1G SLC4A11 | 6.67e-06 | 208 | 164 | 10 | GO:0035725 |
| GeneOntologyBiologicalProcess | lipid transport | ABCA12 ABCA13 VPS13C ATP10B ATP9B APOB ABCA7 ACSL3 SLC22A9 ABCA5 OSBPL3 SLCO1A2 IL1A ANO3 SERPINA5 | 1.32e-05 | 506 | 164 | 15 | GO:0006869 |
| GeneOntologyBiologicalProcess | long-chain fatty-acyl-CoA biosynthetic process | 1.36e-05 | 19 | 164 | 4 | GO:0035338 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1F XCR1 TRPV1 HTR2B TRPC1 GRIN2A GRIN2B RYR2 OPRM1 PKD2 CACNA1I CACNA1H CACNA1G ATP2B1 PLP1 | 1.42e-05 | 509 | 164 | 15 | GO:0006816 |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 1.57e-05 | 40 | 164 | 5 | GO:1990806 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1F TRPV1 ABCC9 SLC12A8 SLC9C2 SLC12A3 SLC6A20 CACNA1I CACNA1H CACNA1G | 1.60e-05 | 230 | 164 | 10 | GO:0098739 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | ABCC9 NMUR1 ANO5 SLC12A8 SLC26A1 SLC12A3 SLCO1A2 ANO3 SLC4A11 | 1.63e-05 | 183 | 164 | 9 | GO:0006820 |
| GeneOntologyBiologicalProcess | fatty acid elongation, polyunsaturated fatty acid | 1.69e-05 | 7 | 164 | 3 | GO:0034626 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, monounsaturated fatty acid | 1.69e-05 | 7 | 164 | 3 | GO:0034625 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, unsaturated fatty acid | 1.69e-05 | 7 | 164 | 3 | GO:0019368 | |
| GeneOntologyBiologicalProcess | organic cation transport | 2.13e-05 | 145 | 164 | 8 | GO:0015695 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | TRPV1 GRIN2A GRIN2B ADGRV1 PKHD1L1 GSDME ATP6V0A4 SCN10A MARVELD2 NIPBL | 2.15e-05 | 238 | 164 | 10 | GO:0050954 |
| GeneOntologyBiologicalProcess | circulatory system process | TRPV1 HTR2B TRPC1 ABCC9 ITGA1 PTGS1 ADCY6 SLC16A12 RYR2 TGFBR3 P2RY1 SLC6A20 SCN10A CACNA1H CACNA1G TACR3 ATP2B1 COL1A2 | 2.27e-05 | 733 | 164 | 18 | GO:0003013 |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | HTR2B CDS2 CYP27A1 ELOVL1 APOB CERS6 PTGS1 ELOVL2 ELOVL7 ACSL3 IGF1R OSBPL3 PGAP2 AGMO TM7SF2 CACNA1H BSCL2 IL1A PLP1 | 2.62e-05 | 813 | 164 | 19 | GO:0008610 |
| GeneOntologyBiologicalProcess | fatty acid elongation, saturated fatty acid | 2.68e-05 | 8 | 164 | 3 | GO:0019367 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | PIEZO1 GRIN2A GRIN2B ADGRV1 RYR2 IGF1R P2RY1 PKD2 SCN10A ANO3 | 2.96e-05 | 247 | 164 | 10 | GO:0009612 |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 3.03e-05 | 23 | 164 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1F XCR1 HTR2B ATP13A1 TRPC1 GRIN2B ATP13A2 SLC9C2 RYR2 P2RY1 ATP6V0A4 PKD2 ATP13A3 IL1A ATP2B1 SLC4A11 | 3.09e-05 | 611 | 164 | 16 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | CACNA1F XCR1 HTR2B ATP13A1 TRPC1 GRIN2B ATP13A2 RYR2 P2RY1 PKD2 ATP13A3 ATP2B1 | 3.15e-05 | 359 | 164 | 12 | GO:0006874 |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 3.55e-05 | 202 | 164 | 9 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 3.55e-05 | 202 | 164 | 9 | GO:0097746 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 3.62e-05 | 24 | 164 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 3.69e-05 | 203 | 164 | 9 | GO:0035150 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1F XCR1 HTR2B ATP13A1 TRPC1 SLC12A8 GRIN2B ATP13A2 RHCE RYR2 SLC12A3 P2RY1 PKD2 ATP13A3 IL1A ATP2B1 | 3.82e-05 | 622 | 164 | 16 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1F XCR1 HTR2B ATP13A1 TRPC1 GRIN2B ATP13A2 SLC9C2 RYR2 P2RY1 ATP6V0A4 PKD2 ATP13A3 IL1A ATP2B1 SLC4A11 | 3.82e-05 | 622 | 164 | 16 | GO:0006873 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 3.88e-05 | 48 | 164 | 5 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 3.88e-05 | 48 | 164 | 5 | GO:1902656 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 5.86e-05 | 27 | 164 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | long-chain fatty-acyl-CoA metabolic process | 5.86e-05 | 27 | 164 | 4 | GO:0035336 | |
| GeneOntologyBiologicalProcess | fatty-acyl-CoA biosynthetic process | 5.86e-05 | 27 | 164 | 4 | GO:0046949 | |
| GeneOntologyBiologicalProcess | blood circulation | TRPV1 HTR2B TRPC1 ABCC9 ITGA1 PTGS1 ADCY6 RYR2 TGFBR3 P2RY1 SCN10A CACNA1H CACNA1G TACR3 ATP2B1 COL1A2 | 6.21e-05 | 648 | 164 | 16 | GO:0008015 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | CACNA1F XCR1 HTR2B ATP13A1 TRPC1 GRIN2B ATP13A2 RYR2 P2RY1 PKD2 ATP13A3 ATP2B1 | 6.83e-05 | 389 | 164 | 12 | GO:0055074 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC9C2 SLC12A3 SLC20A2 SLC6A20 PKD2 SCN10A CACNA1I CACNA1H CACNA1G SLC4A11 | 7.30e-05 | 275 | 164 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5W2 OR8J2 OR8J3 TRPV1 OR8D1 OR2T27 OR5AS1 OR1S2 OR8K5 OR6C65 LY96 RYR2 TAS2R39 TAS2R30 | 7.96e-05 | 524 | 164 | 14 | GO:0009593 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 9.50e-05 | 133 | 164 | 7 | GO:0007200 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 9.88e-05 | 180 | 164 | 8 | GO:0015698 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 9.96e-05 | 134 | 164 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | HTR2B ABCC9 ITGA1 PTGS1 ADCY6 SLC16A12 TGFBR3 P2RY1 SLC6A20 CACNA1G ATP2B1 | 1.00e-04 | 344 | 164 | 11 | GO:0003018 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.03e-04 | 12 | 164 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.03e-04 | 12 | 164 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.06e-04 | 59 | 164 | 5 | GO:0007215 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1F XCR1 HTR2B ABCA12 ATP13A1 TRPC1 SLC12A8 GRIN2B ATP13A2 SLC9C2 RYR2 IGF1R SLC12A3 P2RY1 ATP6V0A4 PKD2 ATP13A3 IL1A ATP2B1 SLC4A11 | 1.06e-04 | 981 | 164 | 20 | GO:0019725 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | TRPV1 SLC19A3 GRIN2B SLC26A1 SLC16A12 ACSL3 SLC22A9 SLC16A5 SLCO1A2 SLC6A20 SLC36A3 IL1A | 1.12e-04 | 410 | 164 | 12 | GO:0046942 |
| GeneOntologyBiologicalProcess | lipid translocation | 1.15e-04 | 60 | 164 | 5 | GO:0034204 | |
| GeneOntologyBiologicalProcess | organic acid transport | TRPV1 SLC19A3 GRIN2B SLC26A1 SLC16A12 ACSL3 SLC22A9 SLC16A5 SLCO1A2 SLC6A20 SLC36A3 IL1A | 1.17e-04 | 412 | 164 | 12 | GO:0015849 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | HTR2B FSTL4 ABCC9 SLC12A8 ITGA1 ATP13A2 PTGS1 ADCY6 TGFBR3 SLC12A3 P2RY1 WASHC5 CACNA1G ULK1 ATP2B1 | 1.28e-04 | 618 | 164 | 15 | GO:0090066 |
| GeneOntologyBiologicalProcess | calcium ion import | 1.33e-04 | 98 | 164 | 6 | GO:0070509 | |
| GeneOntologyBiologicalProcess | very long-chain fatty acid biosynthetic process | 1.33e-04 | 13 | 164 | 3 | GO:0042761 | |
| GeneOntologyBiologicalProcess | G protein-coupled purinergic nucleotide receptor signaling pathway | 1.33e-04 | 13 | 164 | 3 | GO:0035589 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 1.33e-04 | 13 | 164 | 3 | GO:0038003 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 1.48e-04 | 100 | 164 | 6 | GO:0061337 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | TRPV1 PIEZO1 ABCC9 GRID2 GRIK4 GRIN2A GRIN2B RYR2 OPRM1 SCN10A CACNA1I CACNA1H CACNA1G SLC4A11 | 1.57e-04 | 559 | 164 | 14 | GO:0042391 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.68e-04 | 65 | 164 | 5 | GO:0097035 | |
| GeneOntologyBiologicalProcess | signal peptide processing | 1.68e-04 | 14 | 164 | 3 | GO:0006465 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 1.76e-04 | 249 | 164 | 9 | GO:0008016 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.86e-04 | 36 | 164 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | TRPV1 HTR2B VPS13C TRPC1 ACTB ZDHHC7 ABCC9 CASTOR2 GRIN2A GRIN2B HM13 ADCY6 RYR2 OPRM1 TGFBR3 IGF1R PTPRA P2RY1 PKD2 TACR3 IL1A ATP2B1 ADGRL3 | 1.88e-04 | 1272 | 164 | 23 | GO:1901698 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | DOCK10 ACTG1 GRID2 IQGAP1 PTPRA SRGAP3 FARP1 IQSEC1 ADGRL2 ADGRL3 | 1.89e-04 | 309 | 164 | 10 | GO:1901888 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1F XCR1 HTR2B ABCA12 ATP13A1 TRPC1 GRIN2B ATP13A2 SLC9C2 RYR2 IGF1R P2RY1 ATP6V0A4 PKD2 ATP13A3 IL1A ATP2B1 SLC4A11 | 1.90e-04 | 866 | 164 | 18 | GO:0055082 |
| GeneOntologyBiologicalProcess | fatty acid elongation | 2.09e-04 | 15 | 164 | 3 | GO:0030497 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 2.09e-04 | 15 | 164 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | postsynapse organization | ACTB DOCK10 ACTG1 GRID2 GRIN2A GRIN2B IGF1R SRGAP3 FARP1 ADGRL3 | 2.10e-04 | 313 | 164 | 10 | GO:0099173 |
| GeneOntologyBiologicalProcess | action potential | 2.11e-04 | 201 | 164 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | CACNA1F TRPC1 ABCC9 GRIN2A GRIN2B PXK RYR2 SLC30A6 P2RY1 PKD2 SCN10A CACNA1G ATP2B1 PLP1 | 2.17e-04 | 577 | 164 | 14 | GO:0043269 |
| GeneOntologyBiologicalProcess | organic anion transport | TRPV1 SLC19A3 GRIN2B SLC26A1 SLC16A12 ACSL3 SLC22A9 SLC16A5 SLCO1A2 SLC6A20 SLC36A3 IL1A SLC4A11 | 2.50e-04 | 515 | 164 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 2.82e-04 | 40 | 164 | 4 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 2.82e-04 | 40 | 164 | 4 | GO:0032376 | |
| GeneOntologyBiologicalProcess | synaptic signaling | TRPV1 HTR2B RASGRF1 TRPC1 GRID2 GRIK4 GRIN2A GRIN2B ZDHHC3 PXK OPRM1 IGF1R PTPRA P2RY1 FARP1 IQSEC1 SYP CACNA1G PLP1 | 2.87e-04 | 976 | 164 | 19 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of blood circulation | TRPV1 TRPC1 ABCC9 PTGS1 RYR2 SCN10A CACNA1H CACNA1G TACR3 ATP2B1 | 2.91e-04 | 326 | 164 | 10 | GO:1903522 |
| GeneOntologyBiologicalProcess | response to calcium ion | 3.09e-04 | 161 | 164 | 7 | GO:0051592 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | TRPV1 HTR2B TRPC1 ACTB ZDHHC7 ABCC9 CASTOR2 GRIN2A ADCY6 RYR2 OPRM1 IGF1R PTPRA P2RY1 PKD2 ATP2B1 | 3.38e-04 | 752 | 164 | 16 | GO:1901699 |
| GeneOntologyBiologicalProcess | fatty-acyl-CoA metabolic process | 3.41e-04 | 42 | 164 | 4 | GO:0035337 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 3.73e-04 | 4 | 164 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 3.73e-04 | 43 | 164 | 4 | GO:0062149 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RALGDS RASGRF1 DOCK10 ARFGEF2 GPR55 GRIN2A GRIN2B SRGAP3 FARP1 SRGAP1 IQSEC1 ULK1 COL1A2 | 3.80e-04 | 538 | 164 | 13 | GO:0007264 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 4.37e-04 | 224 | 164 | 8 | GO:0007204 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | CUL4B CACNA1F TRPV1 HTR2B PDCD6 PIEZO1 CDS2 ACTB ABCC9 GRIN2A GRIN2B ADGRV1 ABCA7 RYR2 TGFBR3 IGF1R P2RY1 PKD2 SCN10A IL1A NIPBL ANO3 SLC4A11 | 4.92e-04 | 1361 | 164 | 23 | GO:0009628 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | DPAGT1 SEC11B PDCD6 ATP13A1 VPS13C PIEZO1 CDS2 ELOVL1 SEC11C ANO5 ATP10B APOB ERMP1 CERS6 GRIN2A GRIN2B PLD3 HM13 PTGS1 ELOVL2 RYR2 ELOVL7 ACSL3 LMF2 OSBPL3 PGAP2 AGMO PKD2 TM7SF2 BSCL2 ULK1 | 2.50e-08 | 1293 | 165 | 31 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | DPAGT1 SEC11B PDCD6 ATP13A1 VPS13C PIEZO1 CDS2 ELOVL1 SEC11C ANO5 ATP10B APOB ERMP1 CERS6 GRIN2A GRIN2B PLD3 HM13 PTGS1 ELOVL2 RYR2 ELOVL7 ACSL3 LMF2 OSBPL3 PGAP2 AGMO PKD2 TM7SF2 BSCL2 ULK1 | 2.78e-08 | 1299 | 165 | 31 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | DPAGT1 SEC11B PDCD6 ATP13A1 VPS13C PIEZO1 CDS2 ELOVL1 SEC11C ANO5 ATP10B APOB ERMP1 CERS6 GRIN2A GRIN2B PLD3 HM13 PTGS1 ELOVL2 RYR2 ELOVL7 ACSL3 LMF2 OSBPL3 PGAP2 AGMO PKD2 TM7SF2 BSCL2 ULK1 | 4.52e-08 | 1327 | 165 | 31 | GO:0042175 |
| GeneOntologyCellularComponent | basolateral plasma membrane | RASGRF1 TRPC1 SLC26A1 SLC16A12 IQGAP1 SLC22A9 SLC16A5 P2RY1 SLCO1A2 ATP6V0A4 PKD2 MARVELD2 ATP2B1 SLC4A11 | 2.64e-07 | 320 | 165 | 14 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | RASGRF1 TRPC1 ITGA1 SLC26A1 SLC16A12 IQGAP1 SLC22A9 SLC16A5 P2RY1 SLCO1A2 ATP6V0A4 PKD2 MARVELD2 ATP2B1 SLC4A11 | 3.40e-07 | 378 | 165 | 15 | GO:0045178 |
| GeneOntologyCellularComponent | basal plasma membrane | RASGRF1 TRPC1 SLC26A1 SLC16A12 IQGAP1 SLC22A9 SLC16A5 P2RY1 SLCO1A2 ATP6V0A4 PKD2 MARVELD2 ATP2B1 SLC4A11 | 8.88e-07 | 354 | 165 | 14 | GO:0009925 |
| GeneOntologyCellularComponent | cell projection membrane | TRPV1 PDE6A PIEZO1 GRIN2A ADGRV1 ABCA7 ADCY6 OPRM1 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 PKD2 TACR3 ATP2B1 | 1.76e-06 | 431 | 165 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | sodium channel complex | 2.94e-06 | 29 | 165 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 8.22e-06 | 17 | 165 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1F TRPC1 ABCC9 GRID2 GRIK4 GRIN2A GRIN2B RYR2 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 1.00e-05 | 378 | 165 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1F TRPC1 ABCC9 GRIK4 RYR2 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 1.82e-05 | 235 | 165 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | neuron spine | TRPV1 DOCK10 ARFGEF2 GRID2 GRIN2A GRIN2B OPRM1 FARP1 SYP ATP2B1 | 2.78e-05 | 247 | 165 | 10 | GO:0044309 |
| GeneOntologyCellularComponent | transporter complex | CACNA1F TRPC1 ABCC9 GRID2 ATP10B GRIK4 GRIN2A GRIN2B RYR2 ATP6V0A4 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 3.21e-05 | 550 | 165 | 15 | GO:1990351 |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1F TRPV1 HTR2B RASGRF1 DOCK10 ARFGEF2 GRID2 APOB GRIK4 GRIN2A ITGA1 GRIN2B ATP13A2 OPRM1 IGF1R P2RY1 WASHC5 FARP1 CACNA1H CACNA1G TACR3 ULK1 WDFY3 ATP2B1 | 3.60e-05 | 1228 | 165 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | neuron projection membrane | 4.71e-05 | 82 | 165 | 6 | GO:0032589 | |
| GeneOntologyCellularComponent | postsynapse | TRPV1 ACTB DOCK10 ARFGEF2 ACTG1 GRID2 GRIK4 GRIN2A GRIN2B OPRM1 IGF1R P2RY1 SRGAP3 FARP1 IQSEC1 SYP CACNA1H ADGRL2 ATP2B1 ADGRL3 CAP2 | 5.41e-05 | 1018 | 165 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | synaptic membrane | TRPV1 GRID2 GRIK4 GRIN2A GRIN2B OPRM1 PTPRA P2RY1 FARP1 SCN10A SYP CACNA1H ADGRL2 ATP2B1 ADGRL3 | 6.21e-05 | 583 | 165 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | RALGDS ACTB ADGRV1 PKHD1L1 ADCY6 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 | 7.23e-05 | 223 | 165 | 9 | GO:0098862 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1F TRPC1 ABCC9 GRID2 GRIK4 GRIN2A GRIN2B RYR2 ATP6V0A4 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 7.24e-05 | 523 | 165 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | dendrite membrane | 7.96e-05 | 56 | 165 | 5 | GO:0032590 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ACTB DOCK10 ARFGEF2 GRID2 GRIK4 GRIN2A GRIN2B MAL2 IGF1R P2RY1 SRGAP3 FARP1 SCN10A IQSEC1 CACNA1H ADGRL2 ATP2B1 ADGRL3 | 8.42e-05 | 817 | 165 | 18 | GO:0098978 |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1F TRPV1 HTR2B RASGRF1 APOB GRIK4 ITGA1 GRIN2B ATP13A2 OPRM1 IGF1R WASHC5 CACNA1H CACNA1G TACR3 ULK1 WDFY3 ATP2B1 | 1.11e-04 | 835 | 165 | 18 | GO:0043025 |
| GeneOntologyCellularComponent | vesicle membrane | PDCD6 ABCA12 ABCA13 VPS13C ATP10B APOB GRIN2A GRIN2B LY96 PLD3 ATP13A2 ABCA7 IQGAP1 MAL2 ABCA5 WASHC5 ATP6V0A4 PKD2 SYP ATP13A3 ULK1 ATP2B1 SERPINA5 SLC4A11 | 1.18e-04 | 1325 | 165 | 24 | GO:0012506 |
| GeneOntologyCellularComponent | dendritic spine | 1.35e-04 | 242 | 165 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | apical plasma membrane | ABCA7 IQGAP1 MAL2 SLC12A3 P2RY1 ADGRG2 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 MARVELD2 ATP2B1 SLC4A11 | 1.35e-04 | 487 | 165 | 13 | GO:0016324 |
| GeneOntologyCellularComponent | cell body | CACNA1F TRPV1 HTR2B RASGRF1 APOB GRIK4 ITGA1 GRIN2B ATP13A2 OPRM1 IGF1R P2RY1 WASHC5 CACNA1H CACNA1G TACR3 ULK1 WDFY3 ATP2B1 | 1.40e-04 | 929 | 165 | 19 | GO:0044297 |
| GeneOntologyCellularComponent | receptor complex | HTR2B TRPC1 GRID2 GRIK4 GRIN2A ITGA1 GRIN2B ADGRV1 LY96 TGFBR3 IGF1R PTPRA TM7SF2 PLP1 | 2.17e-04 | 581 | 165 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | PDCD6 ABCA12 ABCA13 VPS13C ATP10B APOB GRIN2A GRIN2B LY96 PLD3 ATP13A2 ABCA7 IQGAP1 MAL2 ABCA5 WASHC5 ATP6V0A4 PKD2 SYP ATP13A3 ULK1 ATP2B1 SERPINA5 | 2.52e-04 | 1307 | 165 | 23 | GO:0030659 |
| GeneOntologyCellularComponent | apical part of cell | ACTG1 ABCA7 IQGAP1 MAL2 SLC12A3 P2RY1 ADGRG2 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 MARVELD2 ATP2B1 SLC4A11 | 2.62e-04 | 592 | 165 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | leading edge membrane | 2.71e-04 | 210 | 165 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.81e-04 | 73 | 165 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | endosome | PDCD6 VPS13C ARFGEF2 ATP10B ATP9B APOB GRIN2B LY96 TUBGCP4 ANKRD50 PLD3 ATP13A2 ABCA7 ADCY6 PXK OPRM1 ABCA5 WASHC5 ATP6V0A4 ATP13A3 ULK1 | 3.56e-04 | 1167 | 165 | 21 | GO:0005768 |
| GeneOntologyCellularComponent | presynaptic membrane | 3.66e-04 | 277 | 165 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | postsynaptic membrane | TRPV1 GRID2 GRIK4 GRIN2A GRIN2B OPRM1 P2RY1 FARP1 CACNA1H ADGRL2 ADGRL3 | 3.86e-04 | 405 | 165 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.33e-04 | 45 | 165 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.72e-04 | 46 | 165 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 6.50e-04 | 50 | 165 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1F SEC11B PDCD6 TRPC1 SEC11C ABCC9 GRID2 GRIK4 GRIN2A ITGA1 GRIN2B LY96 HM13 RHCE RYR2 TGFBR3 IGF1R ATP6V0A4 PKD2 SCN10A CACNA1I CACNA1H CACNA1G PLP1 | 7.11e-04 | 1498 | 165 | 24 | GO:0098796 |
| GeneOntologyCellularComponent | vacuolar membrane | GPR137 ABCA13 VPS13C ATP10B PLD3 ATP13A2 ABCA5 ATP6V0A4 GPR137B SLC36A3 ULK1 WDFY3 | 7.19e-04 | 507 | 165 | 12 | GO:0005774 |
| GeneOntologyCellularComponent | signal peptidase complex | 9.10e-04 | 6 | 165 | 2 | GO:0005787 | |
| GeneOntologyCellularComponent | dense body | 1.27e-03 | 7 | 165 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | dendrite | TRPV1 HTR2B RASGRF1 DOCK10 ARFGEF2 GRID2 GRIK4 GRIN2A GRIN2B OPRM1 P2RY1 FARP1 CACNA1H CACNA1G TACR3 ATP2B1 | 1.28e-03 | 858 | 165 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TRPV1 HTR2B RASGRF1 DOCK10 ARFGEF2 GRID2 GRIK4 GRIN2A GRIN2B OPRM1 P2RY1 FARP1 CACNA1H CACNA1G TACR3 ATP2B1 | 1.31e-03 | 860 | 165 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | brush border | 1.33e-03 | 152 | 165 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 1.47e-03 | 155 | 165 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | cell leading edge | TRPV1 PIEZO1 ACTB GRIN2A ADGRV1 ABCA7 IQGAP1 OPRM1 PKD2 TACR3 ATP2B1 | 2.12e-03 | 500 | 165 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 2.15e-03 | 9 | 165 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.67e-03 | 10 | 165 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | late endosome membrane | 3.02e-03 | 179 | 165 | 6 | GO:0031902 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.39e-03 | 78 | 165 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1F ABCC9 GRID2 GRIK4 GRIN2A ITGA1 GRIN2B TGFBR3 IGF1R SCN10A CACNA1I CACNA1H CACNA1G PLP1 | 3.82e-03 | 785 | 165 | 14 | GO:0098797 |
| GeneOntologyCellularComponent | sarcolemma | 4.04e-03 | 190 | 165 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | brush border membrane | 4.24e-03 | 83 | 165 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | presynapse | ACTB ARFGEF2 ACTG1 GRIK4 GRIN2A GRIN2B OPRM1 MAL2 P2RY1 ATP6V0A4 SCN10A IQSEC1 SYP CACNA1H ATP2B1 | 4.50e-03 | 886 | 165 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 4.73e-03 | 43 | 165 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.27e-03 | 141 | 165 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | axon terminus | 6.54e-03 | 210 | 165 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | late endosome | 6.54e-03 | 348 | 165 | 8 | GO:0005770 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 6.82e-03 | 49 | 165 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | terminal bouton | 7.08e-03 | 96 | 165 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | transport vesicle | PDCD6 ABCA12 GRIN2A GRIN2B ATP13A2 MAL2 ATP6V0A4 IQSEC1 SYP ATP2B1 | 8.33e-03 | 519 | 165 | 10 | GO:0030133 |
| GeneOntologyCellularComponent | endosome membrane | VPS13C ATP10B APOB LY96 PLD3 ATP13A2 ABCA7 ABCA5 WASHC5 ATP6V0A4 ATP13A3 | 8.42e-03 | 602 | 165 | 11 | GO:0010008 |
| GeneOntologyCellularComponent | perikaryon | 8.66e-03 | 223 | 165 | 6 | GO:0043204 | |
| GeneOntologyCellularComponent | dendritic spine membrane | 8.72e-03 | 18 | 165 | 2 | GO:0032591 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ARFGEF2 GRID2 GRIK4 GRIN2A GRIN2B MAL2 P2RY1 IQSEC1 SYP CAP2 | 8.76e-03 | 523 | 165 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | transport vesicle membrane | 8.79e-03 | 293 | 165 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | dynein complex | 8.92e-03 | 54 | 165 | 3 | GO:0030286 | |
| MousePheno | impaired ability to fire action potentials | 4.93e-06 | 13 | 131 | 4 | MP:0002578 | |
| Domain | - | 2.81e-07 | 32 | 161 | 6 | 3.40.1110.10 | |
| Domain | - | 2.81e-07 | 32 | 161 | 6 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 4.93e-07 | 35 | 161 | 6 | IPR023299 | |
| Domain | Channel_four-helix_dom | 5.71e-07 | 57 | 161 | 7 | IPR027359 | |
| Domain | - | 5.71e-07 | 57 | 161 | 7 | 1.20.120.350 | |
| Domain | ATPase_P-typ_P_site | 5.88e-07 | 36 | 161 | 6 | IPR018303 | |
| Domain | P_typ_ATPase | 5.88e-07 | 36 | 161 | 6 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.88e-07 | 36 | 161 | 6 | PS00154 | |
| Domain | VDCC_T_a1 | 6.29e-07 | 3 | 161 | 3 | IPR005445 | |
| Domain | ATPase_P-typ_transduc_dom_A | 6.97e-07 | 37 | 161 | 6 | IPR008250 | |
| Domain | E1-E2_ATPase | 6.97e-07 | 37 | 161 | 6 | PF00122 | |
| Domain | VDCCAlpha1 | 1.07e-06 | 10 | 161 | 4 | IPR002077 | |
| Domain | ABC_A | 2.50e-06 | 12 | 161 | 4 | IPR026082 | |
| Domain | GPCR_Rhodpsn_7TM | OR5W2 XCR1 NPBWR2 OR8J3 OR8D1 HTR2B OR2T27 OR5AS1 OR1S2 OR8K5 GPR55 GPR87 NMUR1 OR6C65 GPR139 OPRM1 P2RY1 P2RY14 TACR3 | 5.32e-06 | 670 | 161 | 19 | IPR017452 |
| Domain | 7tm_1 | OR5W2 XCR1 NPBWR2 OR8J3 OR8D1 HTR2B OR2T27 OR5AS1 OR1S2 OR8K5 GPR55 GPR87 NMUR1 OR6C65 GPR139 OPRM1 P2RY1 P2RY14 TACR3 | 6.17e-06 | 677 | 161 | 19 | PF00001 |
| Domain | P-type_TPase_V | 6.21e-06 | 5 | 161 | 3 | IPR006544 | |
| Domain | Ion_trans_dom | 6.50e-06 | 114 | 161 | 8 | IPR005821 | |
| Domain | Ion_trans | 6.50e-06 | 114 | 161 | 8 | PF00520 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5W2 XCR1 NPBWR2 OR8J3 OR8D1 HTR2B OR2T27 OR5AS1 OR1S2 OR8K5 GPR55 GPR87 NMUR1 OR6C65 GPR139 OPRM1 P2RY1 P2RY14 TACR3 | 7.29e-06 | 685 | 161 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5W2 XCR1 NPBWR2 OR8J3 OR8D1 HTR2B OR2T27 OR5AS1 OR1S2 OR8K5 GPR55 GPR87 NMUR1 OR6C65 GPR139 OPRM1 P2RY1 P2RY14 TACR3 | 8.25e-06 | 691 | 161 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5W2 XCR1 NPBWR2 OR8J3 OR8D1 HTR2B OR2T27 OR5AS1 OR1S2 OR8K5 GPR55 GPR87 NMUR1 OR6C65 GPR139 OPRM1 P2RY1 P2RY14 TACR3 | 8.42e-06 | 692 | 161 | 19 | IPR000276 |
| Domain | ELO_CS | 1.23e-05 | 6 | 161 | 3 | IPR030457 | |
| Domain | Lig_chan-Glu_bd | 1.48e-05 | 18 | 161 | 4 | PF10613 | |
| Domain | Glu/Gly-bd | 1.48e-05 | 18 | 161 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.48e-05 | 18 | 161 | 4 | SM00918 | |
| Domain | Iontro_rcpt | 1.48e-05 | 18 | 161 | 4 | IPR001320 | |
| Domain | Iono_rcpt_met | 1.48e-05 | 18 | 161 | 4 | IPR001508 | |
| Domain | Lig_chan | 1.48e-05 | 18 | 161 | 4 | PF00060 | |
| Domain | PBPe | 1.48e-05 | 18 | 161 | 4 | SM00079 | |
| Domain | ELO | 2.15e-05 | 7 | 161 | 3 | PS01188 | |
| Domain | ELO | 2.15e-05 | 7 | 161 | 3 | PF01151 | |
| Domain | ELO_fam | 2.15e-05 | 7 | 161 | 3 | IPR002076 | |
| Domain | ABC_tran | 5.68e-05 | 48 | 161 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.68e-05 | 48 | 161 | 5 | PS50893 | |
| Domain | HAD-like_dom | 6.18e-05 | 79 | 161 | 6 | IPR023214 | |
| Domain | ABC_TRANSPORTER_1 | 6.28e-05 | 49 | 161 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 6.93e-05 | 50 | 161 | 5 | IPR003439 | |
| Domain | GPS | 2.02e-04 | 34 | 161 | 4 | SM00303 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.13e-04 | 14 | 161 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.13e-04 | 14 | 161 | 3 | IPR024743 | |
| Domain | MT | 2.13e-04 | 14 | 161 | 3 | PF12777 | |
| Domain | AAA_8 | 2.13e-04 | 14 | 161 | 3 | PF12780 | |
| Domain | Latrophilin | 2.20e-04 | 3 | 161 | 2 | PF02354 | |
| Domain | NMDAR2_C | 2.20e-04 | 3 | 161 | 2 | PF10565 | |
| Domain | P2Y13_rcpt | 2.20e-04 | 3 | 161 | 2 | IPR008109 | |
| Domain | NMDAR2_C | 2.20e-04 | 3 | 161 | 2 | IPR018884 | |
| Domain | GPR137 | 2.20e-04 | 3 | 161 | 2 | IPR029723 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 2.20e-04 | 3 | 161 | 2 | IPR003334 | |
| Domain | GPS | 2.26e-04 | 35 | 161 | 4 | PF01825 | |
| Domain | - | 2.26e-04 | 64 | 161 | 5 | 3.40.50.1000 | |
| Domain | GPS | 2.53e-04 | 36 | 161 | 4 | PS50221 | |
| Domain | AAA | 2.54e-04 | 144 | 161 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 2.54e-04 | 144 | 161 | 7 | IPR003593 | |
| Domain | DHC_fam | 2.65e-04 | 15 | 161 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.65e-04 | 15 | 161 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.65e-04 | 15 | 161 | 3 | IPR004273 | |
| Domain | ANF_lig-bd_rcpt | 2.81e-04 | 37 | 161 | 4 | IPR001828 | |
| Domain | ANF_receptor | 2.81e-04 | 37 | 161 | 4 | PF01094 | |
| Domain | GPS | 2.81e-04 | 37 | 161 | 4 | IPR000203 | |
| Domain | Peripla_BP_I | 3.46e-04 | 39 | 161 | 4 | IPR028082 | |
| Domain | P5-ATPase | 4.38e-04 | 4 | 161 | 2 | PF12409 | |
| Domain | ABC_transporter_CS | 4.61e-04 | 42 | 161 | 4 | IPR017871 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.50e-04 | 19 | 161 | 3 | IPR004014 | |
| Domain | Gal_Lectin | 7.26e-04 | 5 | 161 | 2 | PF02140 | |
| Domain | GPCR_2_latrophilin | 7.26e-04 | 5 | 161 | 2 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 7.26e-04 | 5 | 161 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 7.26e-04 | 5 | 161 | 2 | PS50228 | |
| Domain | 7tm_2 | 9.00e-04 | 50 | 161 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 9.00e-04 | 50 | 161 | 4 | PS00650 | |
| Domain | MFS_dom | 1.08e-03 | 134 | 161 | 6 | IPR020846 | |
| Domain | Anoct_dimer | 1.51e-03 | 7 | 161 | 2 | PF16178 | |
| Domain | Anoct_dimer | 1.51e-03 | 7 | 161 | 2 | IPR032394 | |
| Domain | Cullin_CS | 1.51e-03 | 7 | 161 | 2 | IPR016157 | |
| Domain | CULLIN | 1.51e-03 | 7 | 161 | 2 | SM00182 | |
| Domain | MARVEL | 1.58e-03 | 27 | 161 | 3 | PF01284 | |
| Domain | Marvel | 1.76e-03 | 28 | 161 | 3 | IPR008253 | |
| Domain | MARVEL | 1.76e-03 | 28 | 161 | 3 | PS51225 | |
| Domain | GPCR_2_secretin-like | 1.78e-03 | 60 | 161 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 1.78e-03 | 60 | 161 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.89e-03 | 61 | 161 | 4 | PS50261 | |
| Domain | Cullin_neddylation_domain | 2.00e-03 | 8 | 161 | 2 | IPR019559 | |
| Domain | Cullin_Nedd8 | 2.00e-03 | 8 | 161 | 2 | PF10557 | |
| Domain | ACTINS_1 | 2.00e-03 | 8 | 161 | 2 | PS00406 | |
| Domain | Cullin_Nedd8 | 2.00e-03 | 8 | 161 | 2 | SM00884 | |
| Domain | ARM-like | 2.41e-03 | 270 | 161 | 8 | IPR011989 | |
| Domain | MFS | 2.44e-03 | 108 | 161 | 5 | PS50850 | |
| Domain | Cullin_homology | 2.55e-03 | 9 | 161 | 2 | IPR016158 | |
| Domain | GPCR_2_secretin-like_CS | 3.09e-03 | 34 | 161 | 3 | IPR017983 | |
| Domain | Cullin | 3.18e-03 | 10 | 161 | 2 | PF00888 | |
| Domain | Anoctamin | 3.18e-03 | 10 | 161 | 2 | PF04547 | |
| Domain | Anoctamin | 3.18e-03 | 10 | 161 | 2 | IPR007632 | |
| Domain | CULLIN_2 | 3.18e-03 | 10 | 161 | 2 | PS50069 | |
| Domain | Cullin_N | 3.18e-03 | 10 | 161 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 3.18e-03 | 10 | 161 | 2 | PS01256 | |
| Domain | IQ | 3.30e-03 | 71 | 161 | 4 | PF00612 | |
| Domain | TRP_channel | 3.86e-03 | 11 | 161 | 2 | IPR004729 | |
| Domain | GAIN_dom_N | 3.86e-03 | 11 | 161 | 2 | IPR032471 | |
| Domain | GAIN | 3.86e-03 | 11 | 161 | 2 | PF16489 | |
| Domain | MFS_1 | 4.42e-03 | 77 | 161 | 4 | PF07690 | |
| Domain | MFS | 4.42e-03 | 77 | 161 | 4 | IPR011701 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CUL1 TRPV1 ABCA12 ATP13A1 TRPC1 ABCC9 ANO5 ATP10B ATP9B APOB ATP13A2 SLC9C2 ABCA7 SLC26A1 ADCY6 RYR2 LMF2 PSME4 SLC12A3 ABCA5 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 ATP2B1 ANO3 | 2.64e-09 | 736 | 130 | 26 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CUL1 TRPV1 ABCA12 ATP13A1 TRPC1 ABCC9 ANO5 ATP10B ATP9B APOB ATP13A2 ABCA7 SLC26A1 RYR2 LMF2 PSME4 SLC12A3 ABCA5 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 ATP2B1 ANO3 | 1.25e-08 | 681 | 130 | 24 | MM14985 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | TRPV1 ATP13A1 TRPC1 ANO5 ATP10B ATP9B ATP13A2 SLC9C2 RYR2 ATP6V0A4 ATP2B1 ANO3 | 1.21e-07 | 183 | 130 | 12 | M997 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | TRPV1 ATP13A1 TRPC1 ANO5 ATP10B ATP9B ATP13A2 RYR2 ATP6V0A4 ATP2B1 ANO3 | 6.75e-07 | 176 | 130 | 11 | MM15718 |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | CACNA1F HTR2B TRPC1 GRIN2A RYR2 CACNA1I CACNA1H CACNA1G TACR3 ATP2B1 | 5.77e-06 | 178 | 130 | 10 | M2890 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | NPBWR2 TRPV1 HTR2B NMUR1 GRID2 GRIK4 GRIN2A GRIN2B OPRM1 P2RY1 P2RY14 TACR3 | 7.98e-06 | 272 | 130 | 12 | M13380 |
| Pathway | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | 4.44e-05 | 22 | 130 | 4 | MM15451 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 5.02e-05 | 44 | 130 | 5 | M11911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 5.34e-05 | 23 | 130 | 4 | M47666 | |
| Pathway | WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS | 6.18e-05 | 9 | 130 | 3 | M48307 | |
| Pathway | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | 6.36e-05 | 24 | 130 | 4 | M1016 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5W2 OR8J2 OR8J3 OR8D1 PDE6A OR2T27 OR5AS1 OR1S2 ACTB OR8K5 ACTG1 APOB OR6C65 SYP TAS2R39 TAS2R30 ATP2B1 | 7.50e-05 | 636 | 130 | 17 | M41834 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 7.52e-05 | 25 | 130 | 4 | M47948 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | TRPC1 ABCC9 ITGA1 RYR2 SCN10A CACNA1I CACNA1H CACNA1G ATP2B1 | 1.09e-04 | 203 | 130 | 9 | M5485 |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.48e-04 | 55 | 130 | 5 | M971 | |
| Pathway | WP_ELONGATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS | 1.59e-04 | 12 | 130 | 3 | MM17077 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.76e-04 | 57 | 130 | 5 | MM15643 | |
| Pathway | WP_GPCRS_NONODORANT | XCR1 HTR2B NMUR1 OPRM1 P2RY1 ADGRG2 P2RY14 TACR3 ADGRL2 ADGRL3 | 1.76e-04 | 266 | 130 | 10 | MM15843 |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.81e-04 | 90 | 130 | 6 | M835 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 2.03e-04 | 32 | 130 | 4 | MM15446 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 2.59e-04 | 14 | 130 | 3 | M39780 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 2.59e-04 | 14 | 130 | 3 | MM15840 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TRPC1 ACTB ACTG1 ITGA1 GRIN2B ADGRV1 PTPRA PSME4 SRGAP3 SRGAP1 SCN10A CACNA1I CACNA1H CACNA1G CAP2 | 2.66e-04 | 575 | 130 | 15 | M29853 |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.24e-04 | 36 | 130 | 4 | M39831 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 3.60e-04 | 37 | 130 | 4 | M729 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.40e-04 | 106 | 130 | 6 | M27200 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 4.74e-04 | 17 | 130 | 3 | MM14552 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 5.65e-04 | 18 | 130 | 3 | M27901 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 5.65e-04 | 18 | 130 | 3 | M524 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 5.98e-04 | 74 | 130 | 5 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 5.98e-04 | 74 | 130 | 5 | M39462 | |
| Pathway | WP_GPCRS_ODORANT | 6.25e-04 | 157 | 130 | 7 | MM15872 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 6.45e-04 | 43 | 130 | 4 | M1429 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 8.29e-04 | 5 | 130 | 2 | M47667 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 8.29e-04 | 5 | 130 | 2 | M49034 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 9.06e-04 | 47 | 130 | 4 | M39853 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.01e-03 | 83 | 130 | 5 | M8728 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 1.04e-03 | 22 | 130 | 3 | M27571 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 1.04e-03 | 22 | 130 | 3 | MM15284 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 1.24e-03 | 6 | 130 | 2 | M47668 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 1.33e-03 | 52 | 130 | 4 | MM15920 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.35e-03 | 24 | 130 | 3 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.35e-03 | 24 | 130 | 3 | M39643 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.53e-08 | 38 | 165 | 6 | 30786075 | |
| Pubmed | 3.37e-08 | 8 | 165 | 4 | 28330839 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | GPR137 HTR2B ATP13A1 ACTB NCKIPSD CERS6 PLD3 ZDHHC3 ABCA7 OPRM1 MFSD14A PTPRA SLC20A2 TM7SF2 CACNA1H ATP2B1 PLP1 | 4.26e-08 | 697 | 165 | 17 | 28298427 |
| Pubmed | 6.04e-08 | 9 | 165 | 4 | 16382099 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 1.05e-07 | 3 | 165 | 3 | 23488970 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 1.05e-07 | 3 | 165 | 3 | 11230107 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 1.05e-07 | 3 | 165 | 3 | 28972185 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 11897840 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 1.05e-07 | 3 | 165 | 3 | 18591418 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 28846697 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 11927664 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 4.18e-07 | 4 | 165 | 3 | 28165634 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 16179592 | ||
| Pubmed | ATP13A1 CDS2 ACTB ELOVL1 DOCK10 ARFGEF2 ACTG1 ERMP1 CERS6 ITGA1 TUBGCP4 HM13 ZDHHC3 ACSL3 LMF2 DCP1B OSBPL3 IQSEC1 ATP13A3 ATP2B1 | 7.80e-07 | 1168 | 165 | 20 | 19946888 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | ATP13A1 PIEZO1 CDS2 SLC12A8 APOB PLD3 HM13 ADCY6 ACSL3 PKD2 TMEM184C BSCL2 ATP13A3 | 8.58e-07 | 499 | 165 | 13 | 22810586 |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 11488959 | ||
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 16899073 | ||
| Pubmed | Characterization of the P5 subfamily of P-type transport ATPases in mice. | 1.04e-06 | 5 | 165 | 3 | 15381061 | |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 15748150 | ||
| Pubmed | Parkinson disease related ATP13A2 evolved early in animal evolution. | 1.04e-06 | 5 | 165 | 3 | 29505581 | |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 19726645 | ||
| Pubmed | RALGDS VPS13C PIEZO1 ERMP1 ADGRV1 ANKRD50 IQGAP1 PSME4 ABCA5 WASHC5 MED12L CACNA1G ADGRL2 | 1.64e-06 | 529 | 165 | 13 | 14621295 | |
| Pubmed | 2.08e-06 | 6 | 165 | 3 | 8761950 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 12103442 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 20661302 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 21664258 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 12900400 | ||
| Pubmed | Calcium signaling induces partial EMT and renal fibrosis in a Wnt4mCherry knock-in mouse model. | 5.40e-06 | 53 | 165 | 5 | 38653356 | |
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 34478646 | ||
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 20110084 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 5.77e-06 | 8 | 165 | 3 | 12761855 | |
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 7.87e-06 | 27 | 165 | 4 | 25269881 | |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 21037510 | ||
| Pubmed | NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. | 8.63e-06 | 9 | 165 | 3 | 16710293 | |
| Pubmed | 9.15e-06 | 28 | 165 | 4 | 8944226 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP13A1 ACTB NCKIPSD ABCC9 GRID2 GRIN2A GRIN2B ADCY6 IGF1R SRGAP3 PKD2 SYP PLP1 | 9.25e-06 | 621 | 165 | 13 | 22794259 |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 1.06e-05 | 29 | 165 | 4 | 15203201 | |
| Pubmed | ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. | 1.23e-05 | 10 | 165 | 3 | 20937905 | |
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 24778262 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 30962377 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 23689133 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 8581564 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 18809727 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.80e-05 | 33 | 165 | 4 | 25713288 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28092666 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 2.24e-05 | 2 | 165 | 2 | 21778137 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25131300 | ||
| Pubmed | Interaction of PLP with GFP-MAL2 in the human oligodendroglial cell line HOG. | 2.24e-05 | 2 | 165 | 2 | 21573057 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 2.24e-05 | 2 | 165 | 2 | 22366783 | |
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 2.24e-05 | 2 | 165 | 2 | 12808460 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 14988077 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21622683 | ||
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 2.24e-05 | 2 | 165 | 2 | 32588558 | |
| Pubmed | Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. | 2.24e-05 | 2 | 165 | 2 | 20921396 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16842630 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25071191 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24157948 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27625340 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27199241 | ||
| Pubmed | The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. | 2.24e-05 | 2 | 165 | 2 | 16901514 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20696923 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23618906 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15010472 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20685979 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19474217 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 36786913 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19850920 | ||
| Pubmed | Importance of the GluN2B carboxy-terminal domain for enhancement of social memories. | 2.24e-05 | 2 | 165 | 2 | 26179233 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10873387 | ||
| Pubmed | Calcium-stimulated disassembly of focal adhesions mediated by an ORP3/IQSec1 complex. | 2.24e-05 | 2 | 165 | 2 | 32234213 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26627919 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10791983 | ||
| Pubmed | Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. | 2.24e-05 | 2 | 165 | 2 | 16033900 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 38214768 | ||
| Pubmed | Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins. | 2.24e-05 | 2 | 165 | 2 | 30792275 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22271578 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 3221869 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21503117 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18372311 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32247039 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23436820 | ||
| Pubmed | Separate functional properties of NMDARs regulate distinct aspects of spatial cognition. | 2.24e-05 | 2 | 165 | 2 | 29764972 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27605622 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31042060 | ||
| Pubmed | Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function. | 2.24e-05 | 2 | 165 | 2 | 33043365 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30355491 | ||
| Pubmed | Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. | 2.24e-05 | 2 | 165 | 2 | 17404231 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30714145 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12127670 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20890276 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16045501 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23303941 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27915379 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 33646123 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21502360 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32849999 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 6686106 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 213279 | ||
| Interaction | LAMP1 interactions | GPR137 ATP13A1 PLD3 ATP13A2 TMPRSS11B IQGAP1 SLC30A6 ACSL3 IGF1R LMF2 SLC20A2 TMEM184C ATP13A3 MARVELD2 ADGRL2 ATP2B1 PLP1 | 6.97e-06 | 644 | 151 | 17 | int:LAMP1 |
| Interaction | TSPAN15 interactions | ATP13A1 PIEZO1 ERMP1 CERS6 ATP13A2 ADCY6 ACSL3 SLC22A9 TM7SF2 ATP13A3 TACR3 | 7.69e-06 | 276 | 151 | 11 | int:TSPAN15 |
| Interaction | SLC31A2 interactions | 9.09e-06 | 38 | 151 | 5 | int:SLC31A2 | |
| Interaction | FPR2 interactions | 9.62e-06 | 138 | 151 | 8 | int:FPR2 | |
| Interaction | YIPF3 interactions | 1.15e-05 | 186 | 151 | 9 | int:YIPF3 | |
| Interaction | C3orf52 interactions | ATP13A1 PIEZO1 ERMP1 ATP13A2 ABCA7 ADCY6 SLC30A6 ABCA5 PKD2 BSCL2 ATP13A3 | 1.96e-05 | 305 | 151 | 11 | int:C3orf52 |
| Interaction | GPR173 interactions | 3.93e-05 | 51 | 151 | 5 | int:GPR173 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 3.87e-05 | 345 | 165 | 8 | chr11q12 | |
| Cytoband | 11q12.1 | 3.04e-04 | 161 | 165 | 5 | 11q12.1 | |
| GeneFamily | Solute carriers | SLC19A3 SLC12A8 SLC9C2 SLC26A1 SLC16A12 SLC30A6 SLC22A9 SLC12A3 SLC16A5 SLC20A2 SLCO1A2 SLC6A20 SLC36A3 SLC4A11 | 4.99e-07 | 395 | 123 | 14 | 752 |
| GeneFamily | ATP binding cassette subfamily A | 1.94e-06 | 14 | 123 | 4 | 805 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 3.04e-06 | 5 | 123 | 3 | 1213 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.72e-05 | 26 | 123 | 4 | 253 | |
| GeneFamily | Dyneins, axonemal | 1.95e-04 | 17 | 123 | 3 | 536 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 2.73e-04 | 4 | 123 | 2 | 918 | |
| GeneFamily | Olfactory receptors, family 8 | 3.41e-04 | 49 | 123 | 4 | 155 | |
| GeneFamily | Actins | 6.76e-04 | 6 | 123 | 2 | 929 | |
| GeneFamily | Transient receptor potential cation channels | 8.89e-04 | 28 | 123 | 3 | 249 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 9.43e-04 | 7 | 123 | 2 | 1201 | |
| GeneFamily | Cullins | 1.25e-03 | 8 | 123 | 2 | 1032 | |
| GeneFamily | Purinergic receptors P2Y | 1.99e-03 | 10 | 123 | 2 | 213 | |
| GeneFamily | Anoctamins | 1.99e-03 | 10 | 123 | 2 | 865 | |
| GeneFamily | ATPase phospholipid transporting | 4.55e-03 | 15 | 123 | 2 | 1210 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | DPAGT1 ATP13A1 PIEZO1 CDS2 ELOVL1 NOL11 ERMP1 PTGS1 ADCY6 IQGAP1 SLC30A6 IFNAR2 MFSD14A TGFBR3 IGF1R LMF2 SLC20A2 ADGRL2 COL1A2 | 4.83e-08 | 681 | 162 | 19 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | DPAGT1 ATP13A1 PIEZO1 CDS2 ELOVL1 NOL11 ERMP1 PTGS1 ADCY6 IQGAP1 SLC30A6 IFNAR2 MFSD14A TGFBR3 IGF1R LMF2 SLC20A2 ADGRL2 COL1A2 | 7.94e-08 | 703 | 162 | 19 | MM1055 |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 1.66e-06 | 177 | 162 | 9 | M7632 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_UP | DPAGT1 CDS2 CYP27A1 SLC12A8 ATP9B CERS6 ACSL3 GSDME GPR137B TMEM184C ATP13A3 IL1A LY75 | 2.35e-06 | 421 | 162 | 13 | M18149 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CUL1 TRPC1 CDS2 CERS6 ELOVL2 ACSL3 TGFBR3 IGF1R PTPRA PSME4 SLC20A2 PKD2 ATP13A3 WDFY3 ATP2B1 NIPBL CAP2 COL1A2 | 6.30e-06 | 856 | 162 | 18 | M4500 |
| Coexpression | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP | DPAGT1 CDS2 SLC12A8 ATP9B CERS6 ACSL3 GSDME GPR137B TMEM184C IL1A LY75 | 9.58e-06 | 341 | 162 | 11 | M12636 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | GPR137 RALGDS HTR2B FSTL4 ELOVL1 DOCK10 ACTG1 ERMP1 CERS6 PLD3 ATP13A2 IFIT3 ADCY6 IFNAR2 ABCA5 OSBPL3 GPR137B SYP P2RY14 SLC4A11 COL1A2 | 2.82e-05 | 1242 | 162 | 21 | M1920 |
| Coexpression | GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP | 3.25e-05 | 197 | 162 | 8 | M8166 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 3.27e-05 | 144 | 162 | 7 | M5942 | |
| Coexpression | GSE39022_LN_VS_SPLEEN_DC_UP | 3.49e-05 | 199 | 162 | 8 | M9017 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN | 3.62e-05 | 200 | 162 | 8 | M5271 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 4.19e-05 | 102 | 162 | 6 | M5601 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 6.40e-05 | 110 | 162 | 6 | M2396 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | GPR137 RALGDS HTR2B FSTL4 ELOVL1 DOCK10 ACTG1 ERMP1 CERS6 PLD3 ATP13A2 IFIT3 ADCY6 IFNAR2 ABCA5 OSBPL3 GPR137B SYP P2RY14 SLC4A11 COL1A2 | 6.48e-05 | 1316 | 162 | 21 | MM1052 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 8.06e-05 | 166 | 162 | 7 | M39026 | |
| Coexpression | STEARMAN_TUMOR_FIELD_EFFECT_UP | 9.77e-05 | 39 | 162 | 4 | M13438 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 1.09e-04 | 121 | 162 | 6 | MM935 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000 | ABCA13 TRPC1 SLC19A3 SEC11C APOB CASTOR2 ITGA1 LY96 IFIT3 SLC16A12 ELOVL2 ELOVL7 MAL2 SLC22A9 GSDME SLC12A3 OSBPL3 ATP6V0A4 GPR137B | 1.09e-05 | 861 | 150 | 19 | gudmap_kidney_adult_RenalCortexMixed_Std_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.76e-05 | 208 | 150 | 9 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k3 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | TMEM45A TRPC1 ABCC9 ITGA1 IFIT3 ADCY6 SLC16A12 ELOVL7 IQGAP1 MAL2 SLC12A3 ATP6V0A4 GPR137B P2RY14 ATP13A3 WDFY3 ATP2B1 CAP2 COL1A2 | 2.17e-05 | 905 | 150 | 19 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.46e-05 | 121 | 150 | 7 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k1 | |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | CYP27A1 LY96 PLD3 ATP13A2 PTGS1 GSDME AGMO GPR137B WDFY3 IL1A ADGRL2 ADGRL3 | 3.04e-05 | 403 | 150 | 12 | GSM605853_500 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | PTGS1 ADCY6 ACSL3 TGFBR3 IGF1R P2RY1 SRGAP3 PKD2 MED12L P2RY14 WDFY3 ADGRL2 | 4.74e-05 | 422 | 150 | 12 | GSM399442_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_500 | 9.15e-05 | 103 | 150 | 6 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.26e-05 | 149 | 150 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F STK36 DNAH10 ABCA12 ABCA13 ANO5 APOB GRIN2B ADGRV1 PKHD1L1 RYR2 ANO3 ADGRL3 | 1.93e-13 | 184 | 163 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F STK36 DNAH10 ABCA12 ABCA13 ANO5 APOB GRIN2B ADGRV1 PKHD1L1 RYR2 ANO3 ADGRL3 | 1.93e-13 | 184 | 163 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F STK36 DNAH10 ABCA12 ABCA13 ANO5 APOB GRIN2B ADGRV1 PKHD1L1 RYR2 ANO3 ADGRL3 | 1.93e-13 | 184 | 163 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | DNAH10 ABCA13 GRIN2B ADGRV1 PKHD1L1 ABCA5 SCN10A TACR3 TRIM60 | 9.06e-09 | 162 | 163 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SLC19A3 FSTL4 ELOVL7 GSDME SLC12A3 ABCA5 OSBPL3 ATP6V0A4 MED12L | 3.45e-08 | 189 | 163 | 9 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SLC19A3 FSTL4 ELOVL7 GSDME SLC12A3 ABCA5 OSBPL3 ATP6V0A4 MED12L | 3.61e-08 | 190 | 163 | 9 | e252e925600e6457fa6e362a55217f4cffa75cdb |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-08 | 196 | 163 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-08 | 198 | 163 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-08 | 198 | 163 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-08 | 198 | 163 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-08 | 198 | 163 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.61e-08 | 200 | 163 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-07 | 179 | 163 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.59e-07 | 181 | 163 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-07 | 183 | 163 | 8 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-07 | 186 | 163 | 8 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.41e-07 | 186 | 163 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-07 | 186 | 163 | 8 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-07 | 187 | 163 | 8 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-07 | 188 | 163 | 8 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.78e-07 | 188 | 163 | 8 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-07 | 189 | 163 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-07 | 189 | 163 | 8 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-07 | 189 | 163 | 8 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-07 | 190 | 163 | 8 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-07 | 190 | 163 | 8 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-07 | 191 | 163 | 8 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.39e-07 | 191 | 163 | 8 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.61e-07 | 192 | 163 | 8 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.31e-07 | 195 | 163 | 8 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.31e-07 | 195 | 163 | 8 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.31e-07 | 195 | 163 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-06 | 160 | 163 | 7 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-06 | 160 | 163 | 7 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-06 | 163 | 163 | 7 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-06 | 163 | 163 | 7 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.48e-06 | 164 | 163 | 7 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.03e-06 | 169 | 163 | 7 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 115 | 163 | 6 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 115 | 163 | 6 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 115 | 163 | 6 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-06 | 179 | 163 | 7 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-06 | 180 | 163 | 7 | fc5b9d0e3215652e490ca72d69f776e9725608b2 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-06 | 180 | 163 | 7 | 6763b22f2383931c747b37cd0ae2f60b08f64d90 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 182 | 163 | 7 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 182 | 163 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 5.12e-06 | 183 | 163 | 7 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 183 | 163 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.31e-06 | 184 | 163 | 7 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 5.50e-06 | 185 | 163 | 7 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 5.70e-06 | 186 | 163 | 7 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 5.70e-06 | 186 | 163 | 7 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.90e-06 | 187 | 163 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.11e-06 | 188 | 163 | 7 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 188 | 163 | 7 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 188 | 163 | 7 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 188 | 163 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.11e-06 | 188 | 163 | 7 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 189 | 163 | 7 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.33e-06 | 189 | 163 | 7 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.55e-06 | 190 | 163 | 7 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.55e-06 | 190 | 163 | 7 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 190 | 163 | 7 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.78e-06 | 191 | 163 | 7 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 191 | 163 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 191 | 163 | 7 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.78e-06 | 191 | 163 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 191 | 163 | 7 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.02e-06 | 192 | 163 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 192 | 163 | 7 | 46ea8f4f292db70420b378c6fa3e55e99413679c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.26e-06 | 193 | 163 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 7.26e-06 | 193 | 163 | 7 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.76e-06 | 195 | 163 | 7 | 60d08fb27469d1e247bc47b651d7023ba82cf92f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.76e-06 | 195 | 163 | 7 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.76e-06 | 195 | 163 | 7 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-06 | 196 | 163 | 7 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.30e-06 | 197 | 163 | 7 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.30e-06 | 197 | 163 | 7 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.57e-06 | 198 | 163 | 7 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.86e-06 | 199 | 163 | 7 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-06 | 200 | 163 | 7 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-06 | 133 | 163 | 6 | f303ab771482281d8793974f9f5279cee09431fe | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 140 | 163 | 6 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-05 | 141 | 163 | 6 | b5e85f89b930a0ec70cc95733c5ab76ac3e9497f | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 145 | 163 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 155 | 163 | 6 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 156 | 163 | 6 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-05 | 158 | 163 | 6 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 160 | 163 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 160 | 163 | 6 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 160 | 163 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.06e-05 | 163 | 163 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.17e-05 | 164 | 163 | 6 | 49733a9d3d95f05056b5b01916060ff20a8de3cf | |
| Drug | AC1L1KS5 | CACNA1F NPBWR2 TRPV1 NCKIPSD GPR87 PLD3 PTGS1 ADCY6 RYR2 P2RY1 PKD2 CACNA1I CACNA1H CACNA1G TACR3 ATP2B1 | 2.54e-09 | 334 | 163 | 16 | CID000005631 |
| Drug | Calcium | CACNA1F RALGDS TRPV1 HTR2B TRPC1 ACTB F8 PTGS1 RYR2 IQGAP1 OPRM1 P2RY1 PKD2 CACNA1I CACNA1H CACNA1G ADGRL2 ATP2B1 COL1A2 | 2.81e-09 | 493 | 163 | 19 | ctd:D002118 |
| Drug | loperamide | CACNA1F GRIN2A GRIN2B RYR2 OPRM1 SLCO1A2 PKD2 CACNA1I CACNA1H CACNA1G | 4.31e-09 | 105 | 163 | 10 | CID000003954 |
| Drug | AC1L1DXE | CACNA1F TRPV1 ACTB ACTG1 GRIK4 GRIN2A GRIN2B PTGS1 RYR2 OPRM1 PKD2 CACNA1I CACNA1H CACNA1G TACR3 | 4.40e-09 | 299 | 163 | 15 | CID000002548 |
| Drug | lamotrigine | CACNA1F GRIN2A GRIN2B PTGS1 RYR2 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 1.14e-08 | 116 | 163 | 10 | CID000003878 |
| Drug | verapamil | CACNA1F PDCD6 ABCA12 ABCA13 ABCC9 APOB ABCA7 ADCY6 RYR2 ABCA5 SLCO1A2 PKD2 SCN10A CACNA1I CACNA1H CACNA1G ATP2B1 COL1A2 | 1.58e-08 | 490 | 163 | 18 | CID000002520 |
| Drug | gabapentin | CACNA1F GRID2 GRIK4 GRIN2A GRIN2B RYR2 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 3.93e-08 | 169 | 163 | 11 | CID000003446 |
| Drug | riluzole | CACNA1F GRID2 GRIK4 GRIN2A GRIN2B RYR2 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 5.31e-08 | 174 | 163 | 11 | CID000005070 |
| Drug | tetradotoxin | TRPV1 HTR2B GRID2 GRIK4 GRIN2A GRIN2B PTGS1 OPRM1 P2RY1 SCN10A SYP P2RY14 CACNA1I CACNA1H CACNA1G TACR3 | 8.19e-08 | 428 | 163 | 16 | CID000020382 |
| Drug | NSC7524 | CACNA1F GRIK4 GRIN2A GRIN2B ADCY6 RYR2 PKD2 SCN10A CACNA1I CACNA1H CACNA1G | 8.41e-08 | 182 | 163 | 11 | CID000005657 |
| Drug | LY215840 | 8.71e-08 | 7 | 163 | 4 | CID000132049 | |
| Drug | CNS 1145 | 1.16e-07 | 33 | 163 | 6 | CID000190902 | |
| Drug | IHC-64 | 1.16e-07 | 33 | 163 | 6 | CID000162753 | |
| Drug | caffeine | CACNA1F PDE6A PDCD6 TRPC1 CYP27A1 GRID2 GRIK4 GRIN2A GRIN2B ADCY6 RYR2 P2RY1 PKD2 P2RY14 CACNA1I CACNA1H CACNA1G ATP2B1 | 1.25e-07 | 562 | 163 | 18 | CID000002519 |
| Drug | Cinnarizine | 3.10e-07 | 9 | 163 | 4 | DB00568 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 3.60e-07 | 3 | 163 | 3 | CID010679219 | |
| Drug | manidipine | 4.16e-07 | 95 | 163 | 8 | CID000004008 | |
| Drug | lanthanum | CACNA1F TRPC1 ADCY6 RYR2 PKD2 CACNA1I CACNA1H CACNA1G ATP2B1 | 6.10e-07 | 136 | 163 | 9 | CID000023926 |
| Drug | Mibefradil | 8.03e-07 | 11 | 163 | 4 | DB01388 | |
| Drug | EBNs | 8.03e-07 | 11 | 163 | 4 | CID000150695 | |
| Drug | nimodipine | CACNA1F GRIN2A GRIN2B RYR2 PKD2 CACNA1I CACNA1H CACNA1G ATP2B1 | 1.05e-06 | 145 | 163 | 9 | CID000004497 |
| Drug | Dantrolene-13C3 | CACNA1F GRIN2A GRIN2B RYR2 PKD2 CACNA1I CACNA1H CACNA1G IL1A | 1.05e-06 | 145 | 163 | 9 | CID000002951 |
| Drug | N-methyl-DL-aspartic acid | CACNA1F HTR2B RASGRF1 TRPC1 GRID2 GRIK4 GRIN2A GRIN2B ADGRV1 PTGS1 RYR2 OPRM1 PKD2 SYP CACNA1I CACNA1H CACNA1G TACR3 | 1.16e-06 | 655 | 163 | 18 | CID000004376 |
| Drug | baclofen | CACNA1F GRIN2A GRIN2B ADCY6 RYR2 OPRM1 PKD2 CACNA1I CACNA1H CACNA1G | 1.24e-06 | 191 | 163 | 10 | CID000002284 |
| Drug | Bay K 8644 | 1.39e-06 | 150 | 163 | 9 | CID000002303 | |
| Drug | myo-inositol | DPAGT1 CACNA1F HTR2B TRPC1 CDS2 GPR87 PLD3 ADCY6 RYR2 IQGAP1 P2RY1 PGAP2 PKD2 P2RY14 CACNA1I CACNA1H CACNA1G BSCL2 TACR3 ATP2B1 | 1.52e-06 | 811 | 163 | 20 | CID000000892 |
| Drug | gadolinium | CACNA1F TRPV1 TRPC1 ADGRV1 F8 RYR2 PKD2 CACNA1I CACNA1H CACNA1G | 1.79e-06 | 199 | 163 | 10 | CID000023982 |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | NPBWR2 EXO5 RASGRF1 RYR2 IGF1R PSME4 SRGAP3 SLC6A20 SYP CACNA1G | 1.79e-06 | 199 | 163 | 10 | 3774_UP |
| Drug | nifedipine | CACNA1F TRPC1 CYP27A1 GRIK4 GRIN2A GRIN2B RYR2 PKD2 CACNA1I CACNA1H CACNA1G TACR3 ATP2B1 COL1A2 | 1.85e-06 | 415 | 163 | 14 | CID000004485 |
| Drug | carbachol | CACNA1F TRPC1 ACTB ACTG1 PLD3 PTGS1 ADCY6 RYR2 P2RY1 PKD2 P2RY14 CACNA1I CACNA1H CACNA1G BSCL2 TACR3 IL1A ATP2B1 | 2.32e-06 | 688 | 163 | 18 | CID000002551 |
| Drug | 2-arachidonoylglycerol (2-AG | 2.32e-06 | 119 | 163 | 8 | CID000001541 | |
| Drug | CP-96,345 | 2.66e-06 | 55 | 163 | 6 | CID000104943 | |
| Drug | Cinildipine | 2.96e-06 | 56 | 163 | 6 | CID000002752 | |
| Drug | Flunarizine | 3.56e-06 | 5 | 163 | 3 | DB04841 | |
| Drug | bepridil | 3.57e-06 | 126 | 163 | 8 | CID000002351 | |
| Drug | pimozide | 3.78e-06 | 127 | 163 | 8 | CID000016362 | |
| Drug | sodium | TRPV1 TRPC1 ACTB ACTG1 GRID2 SLC12A8 GRIK4 SLC26A1 PTGS1 ADCY6 RYR2 SLC12A3 SLC20A2 SLCO1A2 ATP6V0A4 SLC6A20 PKD2 SCN10A SLC36A3 CACNA1H ATP2B1 | 4.11e-06 | 944 | 163 | 21 | CID000000923 |
| Drug | enzacamene | 4.25e-06 | 129 | 163 | 8 | ctd:C038939 | |
| Drug | nilvadipine | 4.47e-06 | 60 | 163 | 6 | CID000004494 | |
| Drug | IAA-94 | 4.92e-06 | 61 | 163 | 6 | CID000003667 | |
| Drug | Frie Mao 1-43 | 4.92e-06 | 61 | 163 | 6 | CID002733618 | |
| Drug | TMB-8 | 5.18e-06 | 176 | 163 | 9 | CID000005494 | |
| Drug | EN-1530 | ACTB ACTG1 GRID2 GRIK4 GRIN2A GRIN2B IFIT3 ADCY6 OPRM1 TACR3 IL1A | 5.49e-06 | 278 | 163 | 11 | CID000004425 |
| Drug | phenylquinone | 5.57e-06 | 36 | 163 | 5 | CID000009688 | |
| Drug | lercanidipine | 5.95e-06 | 63 | 163 | 6 | CID000065866 | |
| Drug | isotetrandrine | 6.34e-06 | 97 | 163 | 7 | CID000005422 | |
| Drug | levo-dromoran tartrate | 6.79e-06 | 98 | 163 | 7 | CID000003918 | |
| Drug | nitrendipine | 6.79e-06 | 98 | 163 | 7 | CID000004507 | |
| Drug | U46619 | CACNA1F ACTB ACTG1 PTGS1 ADCY6 RYR2 P2RY1 PKD2 CACNA1I CACNA1H CACNA1G | 6.95e-06 | 285 | 163 | 11 | CID000005618 |
| Drug | 3,4-dihydroquinazoline | 7.09e-06 | 6 | 163 | 3 | CID000583065 | |
| Drug | Cocaine | CUL4B PDCD6 RASGRF1 ABCC9 SLC12A8 ATP9B GRIN2A GRIN2B RYR2 OPRM1 MAL2 SLC22A9 IGF1R PTPRA PSME4 ABCA5 SLC20A2 SCN10A SYP BSCL2 TACR3 IL1A PLP1 ADGRL3 CAP2 | 7.34e-06 | 1314 | 163 | 25 | ctd:D003042 |
| Drug | octylmethoxycinnamate | 7.39e-06 | 139 | 163 | 8 | ctd:C118580 | |
| Drug | isradipine | 7.76e-06 | 100 | 163 | 7 | CID000003784 | |
| Drug | AC1L1TJF | 7.82e-06 | 66 | 163 | 6 | CID000003377 | |
| Drug | gamma-aminobutyric acid | CUL4B CACNA1F GRIK4 GRIN2A GRIN2B ZDHHC3 RYR2 OPRM1 PKD2 SYP CACNA1I CACNA1H CACNA1G IL1A | 8.49e-06 | 474 | 163 | 14 | CID000000119 |
| Drug | gallopamil | 8.54e-06 | 67 | 163 | 6 | CID000001234 | |
| Drug | arabinosyladenine | TRPV1 ABCA12 ACTB ACTG1 ABCC9 PLD3 F8 PTGS1 ADCY6 RYR2 OPRM1 P2RY1 SLCO1A2 PKD2 P2RY14 IL1A ATP2B1 COL1A2 | 9.45e-06 | 762 | 163 | 18 | CID000000191 |
| Drug | foscarnet | 9.62e-06 | 190 | 163 | 9 | CID000003414 | |
| Drug | NSC759576 | 1.00e-05 | 191 | 163 | 9 | CID000003075 | |
| Drug | AC1L2AC7 | 1.01e-05 | 69 | 163 | 6 | CID000068733 | |
| Drug | ginsenoside Rc | 1.12e-05 | 20 | 163 | 4 | CID000100018 | |
| Drug | ifenprodil | 1.20e-05 | 71 | 163 | 6 | CID000003689 | |
| Drug | lead compounds | 1.29e-05 | 150 | 163 | 8 | CID000073212 | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; HL60; HT_HG-U133A | HTR2B TRPC1 ATP10B ATP13A2 P2RY1 SLC6A20 IQSEC1 SERPINA5 COL1A2 | 1.39e-05 | 199 | 163 | 9 | 2179_UP |
| Drug | CAS 298-57-7 | 1.41e-05 | 73 | 163 | 6 | CID000002761 | |
| Drug | ethosuximide | 1.52e-05 | 74 | 163 | 6 | CID000003291 | |
| Drug | noradrealine | CACNA1F HTR2B ACTB ACTG1 ADCY6 RYR2 OPRM1 P2RY1 SLC6A20 PKD2 P2RY14 CACNA1I CACNA1H CACNA1G IL1A | 1.75e-05 | 575 | 163 | 15 | CID000000951 |
| Drug | butylparaben | 1.80e-05 | 157 | 163 | 8 | ctd:C038091 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | CACNA1F PDE6A HTR2B ACTB ACTG1 GRIN2A GRIN2B PTGS1 ADCY6 RYR2 PKD2 CACNA1I CACNA1H CACNA1G IL1A | 1.82e-05 | 577 | 163 | 15 | CID000000295 |
| Drug | perzinfotel | 1.96e-05 | 8 | 163 | 3 | CID006918236 | |
| Drug | estrone sulfate | 2.02e-05 | 23 | 163 | 4 | ctd:C017296 | |
| Drug | YM90K | 2.02e-05 | 23 | 163 | 4 | CID005486547 | |
| Drug | nisoldipine | 2.06e-05 | 78 | 163 | 6 | CID000004499 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.16e-05 | 161 | 163 | 8 | 3556_DN | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.22e-05 | 79 | 163 | 6 | CID005287890 | |
| Drug | CGP 39653 | 2.41e-05 | 24 | 163 | 4 | CID006437837 | |
| Drug | gavestinel | 2.85e-05 | 25 | 163 | 4 | CID006450546 | |
| Drug | NS3763 | 2.93e-05 | 9 | 163 | 3 | CID004359312 | |
| Drug | phenytoin | 2.97e-05 | 219 | 163 | 9 | CID000001775 | |
| Drug | felodipine | 3.06e-05 | 169 | 163 | 8 | CID000003333 | |
| Drug | lavendustin A | 3.32e-05 | 171 | 163 | 8 | CID000003894 | |
| Drug | L-733,060 | 3.35e-05 | 26 | 163 | 4 | CID000132846 | |
| Drug | AC1L1EKQ | 3.50e-05 | 52 | 163 | 5 | CID000002834 | |
| Drug | potassium | CUL4B CACNA1F TRPC1 ABCC9 SLC12A8 GRIK4 GRIN2A GRIN2B ADCY6 RYR2 SLC12A3 P2RY1 ATP6V0A4 PKD2 SCN10A SLC36A3 CACNA1I CACNA1H CACNA1G ATP2B1 | 3.67e-05 | 1008 | 163 | 20 | CID000000813 |
| Drug | L-689,560 | 3.91e-05 | 27 | 163 | 4 | CID000121918 | |
| Drug | papaverine | 4.08e-05 | 176 | 163 | 8 | CID000004680 | |
| Drug | Icosapent | 4.17e-05 | 10 | 163 | 3 | DB00159 | |
| Drug | nylidrin | 4.17e-05 | 10 | 163 | 3 | CID000004567 | |
| Drug | AC1L1ICP | 4.17e-05 | 10 | 163 | 3 | CID000004520 | |
| Drug | 13-methoxyibogamine | 4.21e-05 | 54 | 163 | 5 | CID000065749 | |
| Drug | AC1L1IZE | 4.49e-05 | 131 | 163 | 7 | CID000004799 | |
| Drug | CAS 520-26-3 | 4.53e-05 | 28 | 163 | 4 | CID000003594 | |
| Drug | C-PP | 4.53e-05 | 28 | 163 | 4 | CID000001228 | |
| Drug | aptiganel | 4.53e-05 | 28 | 163 | 4 | CID000060839 | |
| Drug | 2-amino-4-phosphonobutyric acid | 4.95e-05 | 91 | 163 | 6 | CID000002207 | |
| Drug | streptovirudin | 5.09e-05 | 2 | 163 | 2 | CID006450317 | |
| Drug | BAPTA-AM | TRPC1 ACTB ACTG1 GRIN2A GRIN2B PLD3 ADCY6 P2RY1 P2RY14 ATP2B1 | 5.21e-05 | 293 | 163 | 10 | CID000002293 |
| Drug | AC1NUW3V | 5.23e-05 | 29 | 163 | 4 | CID005462126 | |
| Drug | ketobemidone | 5.23e-05 | 29 | 163 | 4 | CID000010101 | |
| Drug | SQ22536 | 5.44e-05 | 135 | 163 | 7 | CID000005270 | |
| Disease | Colorectal Carcinoma | DPAGT1 RALGDS DNAH3 NPBWR2 ABCA12 ABCA13 OTOP2 ZDHHC7 GPR87 GRID2 APOB GRIN2A LY96 SLC22A9 ABCA5 SLCO1A2 P2RY14 | 1.91e-07 | 702 | 155 | 17 | C0009402 |
| Disease | Allodynia | 3.11e-07 | 84 | 155 | 7 | C0458247 | |
| Disease | Mechanical Allodynia | 3.11e-07 | 84 | 155 | 7 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 3.11e-07 | 84 | 155 | 7 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.11e-07 | 84 | 155 | 7 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.11e-07 | 84 | 155 | 7 | C0751214 | |
| Disease | Tactile Allodynia | 3.11e-07 | 84 | 155 | 7 | C0751213 | |
| Disease | Hyperalgesia | 3.11e-07 | 84 | 155 | 7 | C0020429 | |
| Disease | Dystonia | 3.66e-07 | 86 | 155 | 7 | C0013421 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 2.27e-05 | 11 | 155 | 3 | DOID:9279 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome | 2.74e-05 | 2 | 155 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 2.74e-05 | 2 | 155 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 2.74e-05 | 2 | 155 | 2 | C1853623 | |
| Disease | tumor necrosis factor-alpha measurement | 1.29e-04 | 49 | 155 | 4 | EFO_0004684 | |
| Disease | COVID-19, osteoarthritis | 1.52e-04 | 20 | 155 | 3 | MONDO_0005178, MONDO_0100096 | |
| Disease | fetal alcohol spectrum disorder (biomarker_via_orthology) | 1.63e-04 | 4 | 155 | 2 | DOID:0050696 (biomarker_via_orthology) | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 1.63e-04 | 4 | 155 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 1.63e-04 | 4 | 155 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.88e-04 | 157 | 155 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | Epilepsy | 2.82e-04 | 109 | 155 | 5 | C0014544 | |
| Disease | lymphocyte measurement | 3.91e-04 | 117 | 155 | 5 | EFO_0803546 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 4.23e-04 | 28 | 155 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | adrenoleukodystrophy (implicated_via_orthology) | 5.66e-04 | 7 | 155 | 2 | DOID:10588 (implicated_via_orthology) | |
| Disease | Morphine Abuse | 5.66e-04 | 7 | 155 | 2 | C0600272 | |
| Disease | Uveoretinal Coloboma | 5.66e-04 | 7 | 155 | 2 | C4554007 | |
| Disease | Morphine Dependence | 5.66e-04 | 7 | 155 | 2 | C0026552 | |
| Disease | osteoporosis (is_implicated_in) | 5.74e-04 | 31 | 155 | 3 | DOID:11476 (is_implicated_in) | |
| Disease | response to vaccine, cytokine measurement | 6.56e-04 | 131 | 155 | 5 | EFO_0004645, EFO_0004873 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 7.52e-04 | 8 | 155 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 7.52e-04 | 8 | 155 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 7.52e-04 | 8 | 155 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | response to darapladib, cardiovascular event measurement | 7.52e-04 | 8 | 155 | 2 | EFO_0006919, EFO_0008395 | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 7.52e-04 | 8 | 155 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 7.52e-04 | 8 | 155 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 7.52e-04 | 8 | 155 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | primary dental caries | 7.55e-04 | 34 | 155 | 3 | EFO_0600095 | |
| Disease | Schizophrenia | CACNA1F ABCA13 ACTB GRIK4 GRIN2A GRIN2B PTGS1 OPRM1 PTPRA SRGAP3 SYP TACR3 PLP1 | 8.14e-04 | 883 | 155 | 13 | C0036341 |
| Disease | COVID-19 symptoms measurement | 8.22e-04 | 35 | 155 | 3 | EFO_0600019 | |
| Disease | Congenital ocular coloboma (disorder) | 9.63e-04 | 9 | 155 | 2 | C0009363 | |
| Disease | short-term memory | 9.75e-04 | 83 | 155 | 4 | EFO_0004335 | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.20e-03 | 10 | 155 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | diabetes mellitus biomarker | 1.20e-03 | 10 | 155 | 2 | EFO_0006842 | |
| Disease | Congenital neurologic anomalies | 1.20e-03 | 10 | 155 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.20e-03 | 10 | 155 | 2 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.20e-03 | 10 | 155 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | Tachycardia, Ventricular | 1.46e-03 | 11 | 155 | 2 | C0042514 | |
| Disease | Shortened QT interval | 1.46e-03 | 11 | 155 | 2 | C0151879 | |
| Disease | beta thalassemia (is_marker_for) | 1.46e-03 | 11 | 155 | 2 | DOID:12241 (is_marker_for) | |
| Disease | vascular dementia (is_marker_for) | 1.46e-03 | 11 | 155 | 2 | DOID:8725 (is_marker_for) | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 1.46e-03 | 11 | 155 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | opioid dependence | 1.63e-03 | 237 | 155 | 6 | EFO_0005611 | |
| Disease | upper face morphology measurement | 1.74e-03 | 97 | 155 | 4 | EFO_0010949 | |
| Disease | Lenticulostriate Disorders | 1.75e-03 | 12 | 155 | 2 | C0750951 | |
| Disease | Extrapyramidal Disorders | 1.75e-03 | 12 | 155 | 2 | C0015371 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.75e-03 | 12 | 155 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Basal Ganglia Diseases | 1.75e-03 | 12 | 155 | 2 | C0004782 | |
| Disease | hearing impairment | 1.80e-03 | 98 | 155 | 4 | C1384666 | |
| Disease | oropharynx cancer | 1.83e-03 | 46 | 155 | 3 | EFO_1001931 | |
| Disease | dimethylglycine measurement | 1.83e-03 | 46 | 155 | 3 | EFO_0010476 | |
| Disease | response to antineoplastic agent | 1.87e-03 | 99 | 155 | 4 | GO_0097327 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 1.87e-03 | 99 | 155 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Respiratory Depression | 2.06e-03 | 13 | 155 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 2.06e-03 | 13 | 155 | 2 | C0035229 | |
| Disease | Respiratory Failure | 2.06e-03 | 13 | 155 | 2 | C1145670 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 2.06e-03 | 13 | 155 | 2 | EFO_0800474 | |
| Disease | trauma exposure measurement | 2.20e-03 | 172 | 155 | 5 | EFO_0010703 | |
| Disease | phosphatidylethanolamine measurement | 2.25e-03 | 173 | 155 | 5 | EFO_0010228 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 2.39e-03 | 14 | 155 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 2.39e-03 | 14 | 155 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Alzheimer's disease (is_marker_for) | 2.44e-03 | 257 | 155 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Intellectual Disability | 2.59e-03 | 447 | 155 | 8 | C3714756 | |
| Disease | corneal resistance factor | 2.73e-03 | 451 | 155 | 8 | EFO_0010067 | |
| Disease | heel bone mineral density, urate measurement | 2.80e-03 | 182 | 155 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | pneumonia, COVID-19 | 3.03e-03 | 113 | 155 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | Neuralgia, Supraorbital | 3.13e-03 | 16 | 155 | 2 | C0038870 | |
| Disease | Neuralgia | 3.13e-03 | 16 | 155 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 3.13e-03 | 16 | 155 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 3.13e-03 | 16 | 155 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 3.13e-03 | 16 | 155 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 3.13e-03 | 16 | 155 | 2 | C0423711 | |
| Disease | Abnormal behavior | 3.13e-03 | 16 | 155 | 2 | C0233514 | |
| Disease | Paroxysmal Nerve Pain | 3.13e-03 | 16 | 155 | 2 | C0751373 | |
| Disease | Nerve Pain | 3.13e-03 | 16 | 155 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 3.13e-03 | 16 | 155 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 3.13e-03 | 16 | 155 | 2 | C0042656 | |
| Disease | Colorectal Neoplasms | 3.53e-03 | 277 | 155 | 6 | C0009404 | |
| Disease | Dystonia, Limb | 3.54e-03 | 17 | 155 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 3.54e-03 | 17 | 155 | 2 | C0393610 | |
| Disease | Vascular Diseases | 3.54e-03 | 17 | 155 | 2 | C0042373 | |
| Disease | obsolete aging | 3.66e-03 | 279 | 155 | 6 | GO_0007568 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 3.87e-03 | 121 | 155 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | sweet liking measurement | 3.97e-03 | 18 | 155 | 2 | EFO_0010156 | |
| Disease | Dystonia, Paroxysmal | 3.97e-03 | 18 | 155 | 2 | C0393588 | |
| Disease | Tourette syndrome, schizophrenia | 3.97e-03 | 18 | 155 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | glucose measurement | 4.07e-03 | 380 | 155 | 7 | EFO_0004468 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 4.42e-03 | 19 | 155 | 2 | EFO_0002609, GO_0031427 | |
| Disease | triglyceride measurement, body mass index | 4.42e-03 | 19 | 155 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | Cocaine Abuse | 4.59e-03 | 127 | 155 | 4 | C0009171 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 4.90e-03 | 20 | 155 | 2 | DOID:3328 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VIYNFMGFLTNYLTN | 121 | Q9NVA4 | |
| YVFAAVFNSTMVYSL | 966 | Q8WWZ7 | |
| QYATNYFLMSLAVAD | 86 | P41595 | |
| LTLKMFLFQFVNFYS | 556 | Q75V66 | |
| KIYTVVQFALMLAFY | 336 | Q6ZNB7 | |
| QRYFFQMNQSSLTLL | 141 | O43306 | |
| FMALYSIIQYFSVTL | 941 | Q9H7F0 | |
| FSVIAMSYLISVFFN | 1156 | Q86UK0 | |
| MSYLISVFFNNTNIA | 1161 | Q86UK0 | |
| AMYVAIQAVLSLYAS | 131 | P60709 | |
| AMYVAIQAVLSLYAS | 131 | P63261 | |
| NLYTILTVMLQFFVH | 1051 | Q9HD20 | |
| QLFMTAYFLVSALAE | 381 | O60443 | |
| VNVTFMYLFAIFNTL | 856 | Q8IZP9 | |
| NESTVIMAYLFTIFN | 1076 | Q9HAR2 | |
| NSLQGLYVFMVYFIL | 6141 | Q8WXG9 | |
| FSLQKIVEISYYNMN | 1111 | Q9Y6D5 | |
| NISVFMLSTYQTDFI | 111 | A6NHX0 | |
| QYLMATFVNVYIASF | 386 | O95674 | |
| VVMLSYLLSAFFSQA | 3661 | Q86UQ4 | |
| ETIVMAYLFTIFNAF | 1061 | O95490 | |
| TFALYTSLSIFMNAA | 531 | O60706 | |
| FYIVNQKNTSFMLYV | 231 | Q86XS5 | |
| YILALENQLTMAEYF | 951 | Q9ULJ7 | |
| TMILSSYFINFIYLA | 631 | Q7Z2K6 | |
| HYTIVFNTFVLMQLF | 971 | P20020 | |
| SFLMYFLVSLLYNAT | 1261 | O94823 | |
| FSVSQTMLEEVFLYF | 2086 | Q8IZY2 | |
| MFLFQFVNLNSSIFY | 641 | Q9BYT9 | |
| FMDSVIFTLYNYASN | 1001 | P46940 | |
| TILYSECMVQLFFFV | 91 | Q8WZ84 | |
| FLAVYIINFSANLGM | 31 | Q8NH69 | |
| NYFAYVQMFNSRILT | 176 | Q9H8H0 | |
| SYNASMAQVFFLILL | 91 | A6NJZ3 | |
| FQVSLYKYIFDAMVQ | 216 | Q9H790 | |
| TVNSAAFEYLMFLLI | 1186 | O60840 | |
| FTLNFTINNLRYMAD | 13926 | Q8WXI7 | |
| GIQYLYSTFQALMFT | 146 | Q8NH50 | |
| ISVYMFNLALADFLY | 86 | P47900 | |
| FAILEYTVVLTNMAF | 216 | Q9UHJ9 | |
| DNARSFIYVAVMNYL | 316 | Q8IV08 | |
| FSFLSNVKYNFMRII | 116 | P01583 | |
| ISIDYYNMFTSIFTL | 146 | P35372 | |
| LMLQYSDEFVQSAYL | 276 | Q86YW9 | |
| ALYNMVVQTTALLFF | 226 | Q9HB89 | |
| QFFTLTLMNLYFAQV | 106 | Q96N19 | |
| IISTMQAVFSSVFYF | 941 | O43861 | |
| FSLYGMQVLLFENQY | 806 | Q6DN90 | |
| AFQAQRAFLLMASQY | 81 | P40123 | |
| LFYNYALVIFEMTNL | 111 | P08069 | |
| LLMVYFTNFGNTTIV | 136 | Q9H3H5 | |
| FAQNMEISNLYIYDT | 316 | O43424 | |
| IQVSYEQYLSMVFSI | 176 | O75340 | |
| NFANLIMKVYHLSYL | 216 | P16499 | |
| YETAMRTAQNFLSIF | 1531 | Q6KC79 | |
| NFVLEQLLYFNYMAS | 1296 | O60449 | |
| MAFLVDNLQYYLQVD | 521 | Q9UGJ1 | |
| FSQEYINLLLSMYFF | 96 | Q8TCT9 | |
| KFSSLYISQFIIMYS | 2111 | P00451 | |
| MEQSNYSVYADFILL | 1 | Q8NH04 | |
| YSYEQFLFNTSMLVD | 401 | P23219 | |
| QFNTSYLMENVTIYL | 906 | P56199 | |
| VAQYFPQLLTTLMFQ | 416 | Q5TGP6 | |
| NLVFSMITVLVSYFN | 206 | Q8NGG0 | |
| YAATSIYMINLAVFD | 56 | Q9Y2T6 | |
| YNIFSSIYFLAVMSV | 126 | P48146 | |
| FYANMYTSIVFLGLI | 121 | Q9BY21 | |
| AGQYSSFFLYLRQIM | 261 | Q96MC6 | |
| QIPMYYFLSNLSFLD | 56 | Q8N127 | |
| NAFIFRSLNLVLMVY | 6 | P48551 | |
| HQNLLFVLFLSMYVV | 36 | Q8NGQ3 | |
| YNMLNSAILELFEYI | 596 | Q6ZMV5 | |
| FNIEYSLFASTMLYV | 246 | Q7RTS6 | |
| AFIFSLFLYMKAQVA | 141 | O76062 | |
| NLLFSMIVVLISYFN | 206 | Q8NGG1 | |
| FLNIIYEAYLFSMTQ | 596 | Q8IZD4 | |
| LSQLQTYMIQFDQYI | 2171 | P04114 | |
| YMALYSLTQFISVLI | 936 | Q9NQ11 | |
| FMRLLANYASQNITY | 1256 | P08123 | |
| TYMLFFQVNQSATAL | 1521 | Q96BY6 | |
| ALMTFGNYVLFNLLV | 946 | O43497 | |
| TLSNYIFTAVFLAEM | 1311 | O43497 | |
| LSTFMNAYELYQIEI | 2446 | Q8TD57 | |
| YMLTLVILFLNFYVQ | 241 | Q9NXB9 | |
| KAMITYNFFIVLFSV | 66 | A1L3X0 | |
| QRMFFLFNDVLLYTS | 776 | Q9Y4F1 | |
| FQMAILLQYNTEDAY | 606 | Q13616 | |
| MTFGNYVLFNLLVAI | 846 | Q9P0X4 | |
| REFYMAFQVVQLSLA | 236 | Q6MZW2 | |
| LDSNAVVIMVNYIFF | 191 | P05154 | |
| QVSDMAQLFYYFALE | 201 | Q02318 | |
| NTEFKATMYNLLAYI | 46 | O14879 | |
| IFLITFSYVNNMARV | 216 | Q6ZMG9 | |
| FMIVYNFSLVALSLY | 61 | Q9BW60 | |
| VADLTQINYMYQFSL | 2721 | Q0VDD8 | |
| YNINVAASIFAFMTT | 146 | Q969L2 | |
| VFYAMNSTANYDFVL | 866 | Q12967 | |
| FILYMAAAIVYVNDT | 301 | Q8N4S9 | |
| LKQLYFNLYITVNTM | 71 | Q9Y6Y9 | |
| NMLALLNTAINFFLY | 271 | Q6DWJ6 | |
| YTYIFTNLEFSLQRM | 241 | Q16099 | |
| SNFTFLSVIVLFSYM | 241 | Q96G97 | |
| VALMTFGNYVLFNLL | 996 | O95180 | |
| ALVNSMYQYSLIAFL | 3666 | Q8IVF4 | |
| IVTINFMLTYVAVDY | 386 | A0AV02 | |
| LVSLANMSYFYLNVI | 161 | Q9BZV2 | |
| NMSYFYLNVISLASV | 166 | Q9BZV2 | |
| FYAATIAINVFSIMY | 186 | Q08357 | |
| QEHNLANYLFFLMYL | 4911 | Q92736 | |
| IFLFLDRTYVLQNSM | 306 | Q13620 | |
| TYKYLFIFSVANMRN | 36 | Q9UKD2 | |
| QYYSFTQFALELNEM | 781 | Q9H4L5 | |
| QTDMQYVFIYQALLE | 486 | P18433 | |
| FFTLTLMNLYFTQVI | 126 | O60478 | |
| SLSMFYLLRIANFSN | 101 | P59541 | |
| YIFNAVALFIYLSNM | 271 | P59534 | |
| VALFIYLSNMFDINS | 276 | P59534 | |
| LYSMGALATYIFLQN | 116 | P08247 | |
| ALYAFFNLSLVMSLF | 456 | Q8NBS3 | |
| YYQVLNFAMIVSSAL | 31 | Q9BY50 | |
| MRYLFAFLNHLSQYS | 631 | Q7Z6B7 | |
| AAVFMFAFASLYTQI | 16 | Q9BU23 | |
| IITGNYNFFNLMTLV | 266 | Q9BU23 | |
| YNFFNLMTLVLTTAL | 271 | Q9BU23 | |
| LQQEYSFLLMSDFVV | 271 | Q6ZSM3 | |
| LYYQVLNFGMIVSSA | 6 | P0C7V7 | |
| IFAVATYLHFMLENF | 26 | Q8IVM8 | |
| QYFLILSAMSSFIYS | 511 | P46721 | |
| MRTVTNYFLVNLAFS | 116 | P29371 | |
| DASMAAFNTLVNFIY | 131 | P29371 | |
| VSAVLFYVNMYVSIV | 96 | Q15391 | |
| LNSETIMFLHQIFYQ | 291 | Q13972 | |
| SVVVSFFLSMYYNVI | 91 | Q9NP91 | |
| NEFESVLALVAYYQM | 436 | Q9NZQ3 | |
| QQFSFVLYLGMSIVI | 281 | Q495N2 | |
| TFLQDLMAVIQAYFA | 526 | Q9NRP7 | |
| MSSFQRNLFILAYNY | 401 | O95573 | |
| NQLSFVMNSLYLATF | 456 | P48995 | |
| ISFYNVTEMSLIYNF | 381 | Q8N7C3 | |
| NMIFSISLYSSIFFL | 106 | P46094 | |
| FNATVMASDSIVLFY | 401 | Q9P2K2 | |
| LANQAAMLYVILYFE | 251 | Q12768 | |
| AITNIYMADNANYFI | 406 | Q8IZQ1 | |
| ENNQKYFVLFTMYIA | 166 | Q9NYG2 | |
| NAMFNTYYALAVSVV | 236 | P18577 | |
| LLLDATNNFSYVFYM | 386 | O15375 | |
| MLNAFQNSSIYKEYV | 81 | Q86T26 | |
| MRYLFAFLNHLSQYS | 631 | O43295 | |
| FFLQSLFMLATVVLY | 516 | Q8NER1 | |
| SLYTSFFANLIYFLM | 101 | Q9H2B4 | |
| FYLVNLILAVVTMAY | 386 | Q9Y5Y9 | |
| YVNSILQALFMASDF | 451 | Q9P2H5 | |
| ANYTEIALQQVSMFF | 126 | Q7Z7A4 | |
| QVLFFLVIMVSFANY | 286 | P55017 | |
| VYVHKFFMSLLNFLN | 1706 | Q709C8 | |
| FVSSLNKIAMFQTYA | 256 | Q86WI1 | |
| AIMFFIIFLAYAQLA | 601 | Q13563 | |
| VLTYLQTMVFYNLFI | 1661 | Q14997 | |
| LSFYNMNDRSILYTF | 426 | Q495X7 | |
| SILIHFINMFLFNYS | 611 | Q9HBG4 | |
| YMLIEINNYFAVDTA | 216 | Q6NXT4 | |
| YMNAILQSLFSLQSF | 351 | Q86T82 | |
| NQRFFVLFTMYIALS | 171 | Q9NXF8 | |
| NVSALISINYYFMFL | 636 | Q5TAH2 | |
| YTMLVLIAVYTFQFQ | 636 | Q92508 | |
| MLSNALFVEAFIFYN | 126 | Q9NWC5 | |
| VALYDFQEMANSVYL | 76 | O75385 | |
| ITFNMELYNTDLFLV | 591 | Q03167 | |
| YTVSQMELYQGVNFF | 61 | Q8N1T3 | |
| TFMIAATYNFAVLKL | 256 | P60201 | |
| FLASYTANLAAFMIQ | 641 | Q12879 | |
| IFLASYTANLAAFMI | 641 | Q13224 | |
| YTANLAAFMIQEEYV | 646 | Q13224 |